Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Lahmer T., Salmanton-García J., Marchesi F., El-Ashwah S., Nucci M., Besson C., et al.
Infection , cilt.52, sa.3, ss.1125-1141, 2024 (SCI-Expanded) identifier identifier

The effect of danger-associated molecular patterns on survival in acute graft versus host disease

Çelik S., KAYNAR L., Güven Z. T., Atasever Duran K., KONTAŞ O., KEKLİK M., et al.
Bone Marrow Transplantation , cilt.59, sa.2, ss.189-195, 2024 (SCI-Expanded) identifier identifier

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry

Musto P., Salmanton-García J., Sgherza N., Bergantim R., Farina F., Glenthøj A., et al.
Hematological Oncology , cilt.42, sa.1, 2024 (SCI-Expanded) identifier identifier

Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation

Merter M., Sahin U., İLHAN ., Beksac M.
Journal of Clinical Apheresis , cilt.38, sa.6, ss.685-693, 2023 (SCI-Expanded) identifier identifier

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

Rossi G., Salmanton-García J., Cattaneo C., Marchesi F., Dávila-Valls J., Martín-Pérez S., et al.
International Journal of Infectious Diseases , cilt.137, ss.98-110, 2023 (SCI-Expanded) identifier identifier

The world apheresis association registry, 2023 update

Vrielink H., Le Poole K., Stegmayr B., Kielstein J., Berlin G., İLHAN ., et al.
Transfusion and Apheresis Science , cilt.62, sa.6, 2023 (SCI-Expanded) identifier identifier

Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi study

Arat M., Alacacioglu I., Bolaman A. Z., Buyukasik Y., Cagirgan S., Güvenc B., et al.
Future Oncology , cilt.19, sa.14, ss.975-982, 2023 (SCI-Expanded) identifier identifier

Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome

Beksac M., CENGİZ SEVAL G., Koyun D., TOPÇUOĞLU P., YÜKSEL M., Gurman G., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.23, sa.3, 2023 (SCI-Expanded) identifier identifier

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

Busca A., Salmanton-García J., Marchesi F., Farina F., Seval G. C., Van Doesum J., et al.
Frontiers in Immunology , cilt.14, 2023 (SCI-Expanded) identifier identifier

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Bozdag S. C., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Balkan Medical Journal , cilt.40, sa.3, ss.197-204, 2023 (SCI-Expanded) identifier identifier identifier

Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Kırcalı E., Seval G. C., Öztürk C., Yılmaz H., Koyun D., Bozdağ S. C., et al.
Balkan Medical Journal , cilt.40, sa.1, ss.51-56, 2023 (SCI-Expanded) identifier identifier identifier

Prognostic factors in thrombotic thrombocytopenic purpura

Yalçıner M., İlhan O.
Turkish Journal of Biochemistry , cilt.47, sa.5, ss.626-632, 2022 (SCI-Expanded) identifier identifier

Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients

Gokmen A., Sahin U., Soydan E., Gokgoz Z., Okcu M. K., Ozan U., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.22, sa.10, 2022 (SCI-Expanded) identifier identifier

Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation

DALVA K., HASKOLOĞLU Z. Ş., DALVA AYDEMİR S., Oz M. D., ÖZTÜRK BİRGE A., Ipek S., et al.
Experimental and Clinical Transplantation , cilt.20, sa.10, ss.937-944, 2022 (SCI-Expanded) identifier identifier

Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G. C., Bozdağ S. C., Toprak S. K., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.22, sa.8, ss.596-600, 2022 (SCI-Expanded) identifier identifier

COVID-19 and hairy-cell leukemia: An EPICOVIDEHA survey

Lamure S., Salmanton-García J., Robin-Marieton E., Jaksic O., Kohn M., Marchesi F., et al.
Blood Advances , cilt.6, sa.13, ss.3870-3874, 2022 (SCI-Expanded) identifier identifier

Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

Koyun D., CENGİZ SEVAL G., Kırcalı E., Bozdağ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.
Indian Journal of Hematology and Blood Transfusion , cilt.38, sa.3, ss.601-605, 2022 (SCI-Expanded) identifier identifier

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Soran H., Freiberger T., Harada-Shiba M., Cuchel M., Tromp T. R., Tromp T. R., et al.
The Lancet , cilt.399, sa.10326, ss.719-728, 2022 (SCI-Expanded) identifier identifier

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial

Garcia-Manero G., Mufti G. J., Fenaux P., Buckstein R., Santini V., Díez-Campelo M., et al.
Blood , cilt.139, sa.4, ss.624-629, 2022 (SCI-Expanded) identifier identifier

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları

Bozdağ S. C., Seval G. C., Hindilerden İ. Y., Hindilerden F., Andıç N., Baydar M., et al.
Turkish Journal of Hematology , cilt.39, sa.1, ss.43-54, 2022 (SCI-Expanded) identifier identifier identifier

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Pagano L., Salmanton-García J., Marchesi F., Busca A., Corradini P., Hoenigl M., et al.
Journal of Hematology and Oncology , cilt.14, sa.1, 2021 (SCI-Expanded) identifier identifier

Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor-discontinuation” in chronic myeloid leukemia

İLHAN ., Narli Ozdemir Z., DALVA K., Arslan A., Okay Ozgeyik M., Ipek S., et al.
International Journal of Laboratory Hematology , cilt.43, sa.5, ss.1110-1116, 2021 (SCI-Expanded) identifier identifier

Analysis of extracorporeal photopheresis within the frame of the WAA register

Blaha M., Gasova Z., Berlin G., Audzijoniene J., Griskevicius A., Dykes J., et al.
Transfusion and Apheresis Science , cilt.60, sa.5, 2021 (SCI-Expanded) identifier identifier

Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

Stegmayr B., Newman E., Witt V., Derfler K., Leitner G., Eloot S., et al.
Transfusion Medicine and Hemotherapy , cilt.48, sa.4, ss.234-239, 2021 (SCI-Expanded) identifier identifier

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study

Stilgenbauer S., Bosch F., İLHAN ., Kisro J., Mahé B., Mikuskova E., et al.
British Journal of Haematology , cilt.193, sa.2, ss.325-338, 2021 (SCI-Expanded) identifier identifier

Kronik Lenfositik Lösemide Lösemik İnfiltrasyona Bağlı Akut Böbrek Yetmezliği

Şahin G. K., Kocabay H. E., Kiremitçi S., İlhan O., Keven K.
Turkish Journal of Hematology , cilt.38, sa.2, ss.167-168, 2021 (SCI-Expanded) identifier

Acute kidney injury due to leukemic infiltration in a patient with chronic lymphocytic leukemia Kronik lenfositik lösemide lösemik infiltrasyona bağlı akut böbrek yetmezliği

KUMRU G., Kocabay H. E., KİREMİTCİ S., İLHAN ., KEVEN K.
Turkish Journal of Hematology , cilt.38, sa.2, ss.167-168, 2021 (SCI-Expanded) Creative Commons License identifier identifier

Highlighting the prognostic importance of measurable residual disease among acute myeloid leukemia risk factors Akut myeloid lösemi risk faktörleri arasında ölçülebilir kalıntı hastalığın prognostik öneminin vurgulanması

Özdemir Z. N., Şahin U., Dalva K., Baltacı M. A., Uslu A., Öztürk C., et al.
Turkish Journal of Hematology , cilt.38, sa.2, ss.111-118, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

Narli Ozdemir Z., Cengiz Seval G., Sahin U., Uslu A., Gunduz M., Civriz Bozdag S., et al.
Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.67-75, 2021 (SCI-Expanded) identifier identifier

Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation

Ataca Atilla P., Akkus E., Atilla E., Gokmen N., Civriz Bozdag S., Kurt Yuksel M., et al.
Clinical Transplantation , cilt.34, sa.10, 2020 (SCI-Expanded) identifier identifier

Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

Beksac M., Aydin Y., Goker H., Turgut M., Besisik S. K., Cagirgan S., et al.
Clinical Lymphoma, Myeloma and Leukemia , cilt.20, sa.8, 2020 (SCI-Expanded) identifier identifier

Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation Effets de l'incompatibilité ABO pour l'allogreffe de cellules souches hématopoïétiques

Ataca Atilla P., Akkus E., Atilla E., Gökmen İnan N., Civriz Bozdag S., Kocak Toprak S., et al.
Transfusion Clinique et Biologique , cilt.27, sa.3, ss.115-121, 2020 (SCI-Expanded) identifier identifier

Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

Kuman Tunçel Ö., Kayıkçıoğlu M., Pırıldar Ş., Yılmaz M., Kaynar L., Aktan M., et al.
Journal of Clinical Lipidology , cilt.14, sa.3, ss.361, 2020 (SCI-Expanded) identifier identifier

Luspatercept in patients with lower-risk myelodysplastic syndromes

Fenaux P., Platzbecker U., Mufti G. J., Garcia-Manero G., Buckstein R., Santini V., et al.
New England Journal of Medicine , cilt.382, sa.2, ss.140-151, 2020 (SCI-Expanded) identifier identifier

Who 2016 definition of chronic myeloid leukemia and tyrosine kinase inhibitors Kronik myeloid lösemi who 2016 tanımlaması ve tirozin kinaz inhibitörleri

HAZNEDAROĞLU İ. C., KUZU I., İLHAN .
Turkish Journal of Hematology , cilt.37, sa.1, ss.42-47, 2020 (SCI-Expanded) identifier identifier identifier

Study for the diagnostic screening of paroxysmal nocturnal hemoglobinuria in older patients with unexplained anemia and/or cytopenia

Ozdemir Z. N., İLHAN ., Ozet G., Falay M., YENEREL M. N., Tuglular T., et al.
Clinical Laboratory , cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded) identifier identifier

Evaluation of health and quality of life in apheresis patients – data from the WAA register

Goto J., Newman E., Witt V., Deeren D., Blaha M., Lanska M., et al.
Transfusion and Apheresis Science , cilt.58, sa.5, ss.641-644, 2019 (SCI-Expanded) identifier identifier

Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients

İLHAN ., Ozdemir Z. N., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
Transfusion and Apheresis Science , cilt.58, sa.5, ss.659-662, 2019 (SCI-Expanded) identifier identifier

Who 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors

Haznedaroğlu İ. C., Kuzu I., İLHAN O.
TURKISH JOURNAL OF HAEMATOLOGY , 2019 (SCI-Expanded)

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Dagnew A. F., İLHAN ., Lee W., Woszczyk D., Kwak J., Bowcock S., et al.
The Lancet Infectious Diseases , cilt.19, sa.9, ss.988-1000, 2019 (SCI-Expanded) identifier identifier

A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System

Kilic P., Bay M., Yildirim Y., Coskun O., Seker S., Baydin P., et al.
Cells Tissues Organs , cilt.207, sa.1, ss.15-20, 2019 (SCI-Expanded) identifier identifier

Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Kayikcioglu M., Kuman-Tunçel O., Pirildar S., Yílmaz M., Kaynar L., Aktan M., et al.
Journal of Clinical Lipidology , cilt.13, sa.3, ss.455-467, 2019 (SCI-Expanded) identifier identifier

Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft

Varan H. D., BAY M., ÖZTÜRK BİRGE A., DALVA K., İLHAN .
Transfusion and Apheresis Science , cilt.58, sa.2, ss.192-195, 2019 (SCI-Expanded) identifier identifier

Early initiation of extracorporeal photochemotherapy increases response for chronic graft versus host disease following steroid failure L'initiation précoce de la photochimiothérapie extracorporelle augmente la réponse pour la maladie chronique du greffon contre l'hôte après échec des stéroïdes

Gunduz M., Atilla E., Atilla P., TOPÇUOĞLU P., İLHAN .
Transfusion Clinique et Biologique , cilt.26, sa.1, ss.32-37, 2019 (SCI-Expanded) identifier identifier

Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Koçak A. A., Karatayli S. C., et al.
Turkish Journal of Gastroenterology , cilt.30, sa.11, ss.957-963, 2019 (SCI-Expanded) identifier identifier identifier

Promising utilization areas of therapeutic plasmapheresis in cardiovascular surgery practice

Durdu M. S., Cakici M., Gumus F., Deniz G. C., Bozdag S. C., ÖZÇINAR E., et al.
Transfusion and Apheresis Science , cilt.57, sa.6, ss.762-767, 2018 (SCI-Expanded) identifier identifier

Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
Hematology , cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded) identifier identifier

What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

Kayikcioglu M., Tokgozoglu L., Dogan V., Ceyhan C., Tuncez A., Kutlu M., et al.
Atherosclerosis , cilt.277, ss.341-346, 2018 (SCI-Expanded) identifier identifier

Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA external quality assessment national program results MOTAKK HBV DNA ve HCV RNA diş kalite kontrol ulusal programi 2015-2016 sonuçlarinin deǧerlendirilmesi

Karatayli E., Soydemir E., Aksoy Z. B., Kizilpinar M., Altay Koçak A., Karatayli S. C., et al.
Mikrobiyoloji Bulteni , cilt.52, sa.4, ss.348-366, 2018 (SCI-Expanded) identifier identifier identifier

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study

Stilgenbauer S., Leblond V., Foà R., Böttcher S., İLHAN ., Knauf W., et al.
Leukemia , cilt.32, sa.8, ss.1778-1786, 2018 (SCI-Expanded) identifier identifier

JACIE: A 20 year-old voluntary body functioning worldwide

YÜKSEL M., İLHAN .
Transfusion and Apheresis Science , cilt.57, sa.2, ss.153-158, 2018 (SCI-Expanded) identifier identifier

Editorial

İLHAN .
Transfusion and Apheresis Science , cilt.57, sa.2, ss.150, 2018 (SCI-Expanded) identifier

Biography

İLHAN .
Transfusion and Apheresis Science , cilt.57, sa.2, ss.151, 2018 (SCI-Expanded) identifier

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: Primary analysis of the randomized, open-label mable study

Michallet A., Aktan M., Hiddemann W., İLHAN ., Johansson P., Laribi K., et al.
Haematologica , cilt.103, sa.4, ss.698-706, 2018 (SCI-Expanded) identifier identifier

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Kayikcioglu M., Tokgozoglu L., Yilmaz M., Kaynar L., Aktan M., Durmuş R. B., et al.
Atherosclerosis , cilt.270, ss.42-48, 2018 (SCI-Expanded) identifier identifier

Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

Atilla E., Yalciner M., Atilla P. A., Ates C., Bozdag S. C., Yuksel M. K., et al.
Antiviral Therapy , cilt.23, sa.8, ss.647-653, 2018 (SCI-Expanded) identifier identifier

Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: A retrospective study

Atilla E., Sahin D., Atilla P. A., DOLAPÇI G. İ., TEKELİ F. A., Bozdag S. C., et al.
Antiviral Therapy , cilt.23, sa.6, ss.523-527, 2018 (SCI-Expanded) identifier identifier

DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia

Ozdogan H., GÜR DEDEOĞLU B., Oztemur Islakoglu Y., Aydos A., KÖSE S., ATALAY A., et al.
Leukemia Research , cilt.63, ss.62-71, 2017 (SCI-Expanded) identifier identifier

Extracorporeal photochemotherapy in mycosis fungoides Photochimiothérapie extracorporelle dans les mycoses fongiques

Atilla E., Atilla P., Bozdag S., Yuksel M., Toprak S., Topcuoglu P., et al.
Transfusion Clinique et Biologique , cilt.24, sa.4, ss.454-457, 2017 (SCI-Expanded) identifier identifier

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: The randomized MabEase study

Lugtenburg P., Avivi I., Berenschot H., İLHAN ., Marolleau J. P., Nagler A., et al.
Haematologica , cilt.102, sa.11, ss.1913-1922, 2017 (SCI-Expanded) identifier identifier

Subsequent malignancies after allogeneic hematopoietic stem cell transplantation

Gündüz M., Özen M., Şahin U., Toprak S. K., Civriz Bozdağ S., Kurt Yüksel M., et al.
Clinical Transplantation , cilt.31, sa.7, 2017 (SCI-Expanded) identifier identifier

Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

ÖZEN M., ÜSTÜN C., ÖZTÜRK B., TOPÇUOĞLU P., ARAT M., GÜNDÜZ M., et al.
Turkish Journal of Hematology , cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded) identifier identifier identifier identifier

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

SOYER N., HAZNEDAROĞLU İ. C., CÖMERT M., ÇEKDEMİR D., YILMAZ M., ÜNAL A., et al.
Turkish Journal of Hematology , cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded) identifier identifier identifier identifier

The effect of age on peripheral stem cell mobilization in healthy donors, single center experience

Ozen M., Gunduz M., TOPÇUOĞLU P., TOPRAK S. K., DALVA K., Gurman G., et al.
Journal of Clinical Apheresis , cilt.32, sa.1, ss.16-20, 2017 (SCI-Expanded) identifier identifier

Multicenter retrospective analysis of turkish patients with chronic myeloproliferative neoplasms Kronik miyeloproliferatif neoplazi tanılı türk hastaların geriye dönük ve çok merkezli analizi

Soyer N., HAZNEDAROĞLU İ. C., Cömert M., Çekdemir D., Yılmaz M., ÜNAL A., et al.
Turkish Journal of Hematology , cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded) Creative Commons License identifier identifier

Allogeneic transplantation in chronic myeloid leukemia and the effect of tyrosine kinase inhibitors on survival: A quasi-experimental study Kronik myeloit lösemide allojenik nakil ve tirozin kinaz inhibitörlerinin sağkalıma etkisi bir öncesi-sonrası çalışması

Özen M., Üstün C., Öztürk B., Topçuoğlu P., Arat M., Gündüz M., et al.
Turkish Journal of Hematology , cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded) Creative Commons License identifier identifier

Constitutional Trisomy 8 Mosaicism with Persistent Macrocytosis

Altlner Ş., KUTLAY N., İLHAN .
Cytogenetic and Genome Research , cilt.150, sa.1, ss.35-39, 2017 (SCI-Expanded) identifier identifier

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., AYYILDIZ O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
Uluslararası Hematoloji-Onkoloji Dergisi , cilt.26, sa.Suppl 1, ss.12-19, 2016 (SCI-Expanded) identifier identifier

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

O'Brien S., Jones J. A., Coutre S. E., Mato A. R., Hillmen P., Tam C., et al.
The Lancet Oncology , cilt.17, sa.10, ss.1409-1418, 2016 (SCI-Expanded) identifier identifier

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase

Saydam G., Haznedaroglu I. C., Kaynar L., Yavuz A. S., Ali R., Guvenc B., et al.
Expert Opinion on Pharmacotherapy , cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded) identifier identifier

A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction

ÖZEN M., YILMAZ G., COŞKUN B., TOPÇUOĞLU P., ÖZTÜRK B., GÜNDÜZ M., et al.
Turkish Journal of Hematology , cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded) identifier identifier identifier identifier

Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates

Tekgündüz E., Şencan I., Kapuağasi A., Ünal D., Öztürk M., Gümüş E., et al.
Transfusion and Apheresis Science , cilt.54, sa.1, ss.53-59, 2016 (SCI-Expanded) identifier identifier

A quasi-experimental study analyzing the effectiveness of portable high-efficiency particulate absorption filters in preventing infections in hematology patients during construction İnşaat esnasında hematoloji hastalarında gelişen enfeksiyonların önlenmesinde portabl yüksek etkinlikte partikül emici filtrelerin etkinliğinin değerlendirildiği bir öncesi sonrası Çalışması

Özen M., Yılmaz G., Coşkun B., Topçuoğlu P., Öztürk B., Gündüz M., et al.
Turkish Journal of Hematology , cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Idelalisib at the crossroads of B-cell lymphoproliferative disorders B-Hücreli lenfoproliferatif hastalıkların dönüm noktası İdelalisib

AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.26, ss.12-19, 2016 (SCI-Expanded) Creative Commons License identifier

Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center

ÖZEN M., BOZDAG S. C., CAKMAK G., TOPÇUOĞLU P., EROGLU A. H., GÜNDÜZ M., et al.
Uluslararası Hematoloji-Onkoloji Dergisi , cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded) identifier identifier

Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting

CAN A., Ulus A. T., ÇINAR Ö., TOPAL ÇELİKKAN F., Simsek E., AKYOL M., et al.
Stem Cell Reviews and Reports , cilt.11, sa.5, ss.752-760, 2015 (SCI-Expanded) identifier identifier

Peripheral blood stem cell mobilization and collection from elderly patients and elderly healthy donor

Bozdag S. C., İLHAN .
Transfusion and Apheresis Science , cilt.53, sa.1, ss.8-12, 2015 (SCI-Expanded) identifier identifier

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial

Jaeger U., Trneny M., Melzer H., Praxmarer M., Nawarawong W., Yehuda D. B., et al.
Haematologica , cilt.100, sa.7, ss.955-963, 2015 (SCI-Expanded) identifier identifier

Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz S., Dal M. S., Berber I., Sahin D. G., Dogu M. H., Ayyildiz O., et al.
Geriatrics and Gerontology International , cilt.15, sa.6, ss.729-735, 2015 (SCI-Expanded) identifier identifier

Hyperviscosity in renal transplant recipients

Tutal E., Erkmen Uyar M., Uyanik S., Bal Z., Guliyev O., TOPRAK S. K., et al.
Transplantation Proceedings , cilt.47, sa.4, ss.1165-1169, 2015 (SCI-Expanded) identifier identifier

Antilymphocyte/thymocyte globulin for the treatment of steroid-refractory acute graft-versus-host disease: 20-year experience at a single center Steroide dirençli akut graft versus host hastalığının tedavisinde antilenfosit / Timosit globulin: Bir merkezdeki 20 yıllık deneyim

Ozen M., Bozdag S. C., Cakmak G., TOPÇUOĞLU P., EROĞLU A. H., Gunduz M., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded) identifier

Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey

Berber I., Erkurt M. A., Keklik M., Dogu M. H., Terzi H., Pala C., et al.
Acta Medica Mediterranea , cilt.31, sa.6, ss.1195-1202, 2015 (SCI-Expanded) identifier

Therapeutic plasmapheresis in geriatric patients: Favorable results

Ataca P., Marasuna O. A., Ayyildiz E., BAY M., İLHAN .
Transfusion and Apheresis Science , cilt.51, sa.3, ss.64-67, 2014 (SCI-Expanded) identifier identifier

Şiddetli Kardiyak Allogreft Rejeksiyonu Olan Bir Hastada Ekstrakorporeal Fotoferez Sonrası Quilty Etkisi

ÖZCAN Ö. U., SAYIN T., SÖĞÜT G., HEPER A., GÖKSÜLÜK H., VURGUN V. K., et al.
Turkish Journal of Hematology , cilt.31, sa.4, ss.90-91, 2014 (SCI-Expanded) identifier

Ibrutinib: From Molecule to Medicine

AYYILDIZ O., DEMİRKAN F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L. G., et al.
Uluslararası Hematoloji-Onkoloji Dergisi , cilt.253, ss.4-14, 2014 (SCI-Expanded) identifier

Ibrutinib: From Molecule to Medicine İbrutinib: Molekülden İlaca

Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., İLHAN ., KAYNAR L., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded) identifier

Quilty effect after extracorporeal photopheresis in a patient with severe refractory cardiac allograft rejection Şiddetli Kardiyak Allogreft Rejeksiyonu Olan Bir Hastada Ekstrakorporeal Fotoferez Sonrası Quilty Etkisi

Özcan Ö. U., SAYIN T., Soğut G., HEPER A., Göksülük H., Vurgun V. K., et al.
Turkish Journal of Hematology , cilt.31, sa.4, ss.430-431, 2014 (SCI-Expanded) identifier identifier

The treatment of acquired hemophilia with combination therapy of immunosuppressives and immunoadsorption Kazani{dotless}lmi{dotless}ş hemofilinin immunsupresif ve immunadsorbsiyon kombinasyonu ile tedavisi

Bilgin A. U., ÖZCAN M., Ayyildiz E., İLHAN .
Turkish Journal of Hematology , cilt.31, sa.2, ss.194-196, 2014 (SCI-Expanded) identifier identifier

RHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients

Erkmen Uyar M., TOPRAK S. K., Saglam H., Tutal E., BAY M., İLHAN ., et al.
The Scientific World Journal , cilt.2013, 2013 (SCI-Expanded) identifier identifier

Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

Kaya E., Keklik M., Şencan M., Yilmaz M., Keskin A., Kiki I., et al.
Transfusion and Apheresis Science , cilt.48, sa.3, ss.349-352, 2013 (SCI-Expanded) identifier identifier

Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study

Korkmaz S., Keklik M., Sivgin S., Yildirim R., Tombak A., Kaya M. E., et al.
Transfusion and Apheresis Science , cilt.48, sa.3, ss.353-358, 2013 (SCI-Expanded) identifier identifier

Double filtration plasmapheresis for a case of Crimean-Congo hemorrhagic fever

MEÇO B. C., MEMİKOĞLU K. O., İLHAN ., Ayyildiz E., Gunt C., ÜNAL M. N., et al.
Transfusion and Apheresis Science , cilt.48, sa.3, ss.331-334, 2013 (SCI-Expanded) identifier identifier

Review of therapeutic options and the management of patients with myelodysplastic syndromes

Özcan M. A., İLHAN ., Ozcebe O. I., Nalcaci M., Gülbas Z.
Expert Review of Hematology , cilt.6, sa.2, ss.165-189, 2013 (SCI-Expanded) identifier identifier

Turkish chronic myeloid leukemia study: Retrospective sectional analysis of CML patients

ŞAHİN F., SAYDAM G., CÖMERT M., UZ B., YAVUZ A. S., TURAN E., et al.
Turkish Journal of Hematology , cilt.30, sa.4, ss.351-358, 2013 (SCI-Expanded) identifier

İnflamatuvar barsak hastalıklarında adzorptif lökositaferez uygulaması: İlk sonuçlarımız oldukça cesaret verici

TÖRÜNER M., TOPRAK S. K., MIZRAK K., YILDIRIM Y., BAY M., AYYILDIZ E., et al.
Turkish Journal of Hematology , cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded) identifier

Adsorptive leukocytapheresis in inflammatory bowel diseases: Our preliminary results are encouraging İnfl amatuvar Barsak Hastalıklarında Adzorptif Lo̧kositaferez Uygulamas?: Ïlk Sonuçlarımız Oldukça Cesaret Verici

TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., BAY M., Ayyildiz E., et al.
Turkish Journal of Hematology , cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded) identifier identifier

Turkish Apheresis Activity for 2011

ALTUNTAŞ F., Unal A., İLHAN .
Transfusion and Apheresis Science , cilt.47, sa.1, ss.57-58, 2012 (SCI-Expanded) identifier identifier

Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells

Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .
Transfusion and Apheresis Science , cilt.47, sa.1, ss.113-116, 2012 (SCI-Expanded) identifier identifier

Plerixafor use in patients with previous mobilization failure: A multicenter experience

Tekgündüz E., Altuntaş F., Şivgin S., Aki Ş. Z., Dönmez A., Topçuoĝlu P., et al.
Transfusion and Apheresis Science , cilt.47, sa.1, ss.77-80, 2012 (SCI-Expanded) identifier identifier

Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products

Civriz Bozdag S., BAY M., Ayyildiz E., TOPÇUOĞLU P., İLHAN .
Transfusion and Apheresis Science , cilt.47, sa.1, ss.117-120, 2012 (SCI-Expanded) identifier identifier

Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients

TOPÇUOĞLU P., Arat M., ÖZCAN M., ARSLAN Ö., İLHAN ., Beksac M., et al.
Annals of Hematology , cilt.91, sa.4, ss.577-586, 2012 (SCI-Expanded) identifier identifier

Therapeutic plasma exchange in an intensive care unit (ICU): A 10-year, single-center experience

OZANSOY A., CAN Ö., Oral M., ÜNAL M. N., Ayyildiz E., İLHAN ., et al.
Transfusion and Apheresis Science , cilt.45, sa.2, ss.161-166, 2011 (SCI-Expanded) identifier identifier

The management of Chronic Myeloid Leukemia in the era of second generation tyrosine kinase Inhibitors

HAZNEDAROĞLU İ. C., Cetiner M., İLHAN .
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.21, sa.2 SUPPL. 1, ss.1-3, 2011 (SCI-Expanded) identifier

Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial

Beksac M., Ali R., Ozcelik T., ÖZCAN M., Ozcebe O., BAYIK M. M., et al.
Leukemia Research , cilt.35, sa.3, ss.340-345, 2011 (SCI-Expanded) identifier identifier

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Gupta V., Eapen M., Brazauskas R., Carreras J., Aljurf M., Gale R. P., et al.
Haematologica , cilt.95, sa.12, ss.2119-2125, 2010 (SCI-Expanded) identifier identifier

The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment

Sari T., YÜKSEL M., TOPÇUOĞLU P., BAY M., Ayyildiz E., ÖZCAN M., et al.
Transfusion and Apheresis Science , cilt.43, sa.3, ss.315-320, 2010 (SCI-Expanded) identifier identifier

Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy

ŞANLI H., AKAY B. N., Ayyildiz E., Anadolu R., İLHAN .
Transfusion and Apheresis Science , cilt.43, sa.3, ss.353-359, 2010 (SCI-Expanded) identifier identifier

Chronic myeloid leukemia: Practical issues in diagnosis, treatment and follow-up

Buyukasik Y., Haznedaroglu I. C., İLHAN .
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.20, sa.2 SUPPL., ss.1-12, 2010 (SCI-Expanded) identifier

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

Shaughnessy P., Bolwell B., Van Besien K., Mistrik M., Grigg A., Dodds A., et al.
Bone Marrow Transplantation , cilt.45, sa.6, ss.1068-1076, 2010 (SCI-Expanded) Creative Commons License identifier identifier

Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: A prospective randomized study

Koruk S., Mizrak A., Kaya Ugur B., İLHAN ., Baspinar O., Oner U.
Clinical Therapeutics , cilt.32, sa.4, ss.701-709, 2010 (SCI-Expanded) identifier identifier

The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: A pilot study

YÜKSEL M., TOPÇUOĞLU P., Kurdal M., İLHAN .
Cytotherapy , cilt.12, sa.1, ss.38-44, 2010 (SCI-Expanded) identifier identifier

Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: A randomized evaluation of early vs late administration of recombinant human G-CSF

Ozcelik T., TOPÇUOĞLU P., Beksac M., ÖZCAN M. E., Arat M., Bykl Z., et al.
Bone Marrow Transplantation , cilt.44, sa.12, ss.779-783, 2009 (SCI-Expanded) identifier identifier

Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia

Sayitoglu M., Haznedaroǧlu I. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
Journal of International Medical Research , cilt.37, sa.4, ss.1018-1028, 2009 (SCI-Expanded) identifier identifier

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

Fenske T. S., Hari P. N., Carreras J., Zhang M., Kamble R. T., Bolwell B. J., et al.
Biology of Blood and Marrow Transplantation , cilt.15, sa.11, ss.1455-1464, 2009 (SCI-Expanded) identifier identifier

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

Lee S. J., Kukreja M., Wang T., Giralt S. A., Szer J., Arora M., et al.
Blood , cilt.112, sa.8, ss.3500-3507, 2008 (SCI-Expanded) identifier identifier

A case report of the Modified Malmö Protocol: An alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura

Yazman D., Konuk N., ÖZCAN M., Arat M., SOYDAN E., ARSLAN Ö., et al.
Therapeutic Apheresis and Dialysis , cilt.12, sa.3, ss.255-258, 2008 (SCI-Expanded) identifier identifier

Vitiligo after hematopoietic cell transplantation: Six cases and review of the literature

ŞANLI H., AKAY B. N., Arat M., KOÇYİĞİT P., Akan H., Beksac M., et al.
Dermatology , cilt.216, sa.4, ss.349-354, 2008 (SCI-Expanded) identifier identifier

HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTR

Schlenk R. F., Pasquini M. C., Pérez W. S., Zhang M., Krauter J., Antin J. H., et al.
Biology of Blood and Marrow Transplantation , cilt.14, sa.2, ss.187-196, 2008 (SCI-Expanded) identifier identifier

Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: An ex vivo experimental study

BAY M., AKAR A. R., Durdu S., Ayyildiz E., İLHAN .
Cytotherapy , cilt.10, sa.1, ss.98-99, 2008 (SCI-Expanded) identifier identifier

How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight

TOPÇUOĞLU P., SOYDAN E., Ekiz F., Ayyildiz E., DALVA K., ÖZCAN M., et al.
Transfusion and Apheresis Science , cilt.36, sa.3, ss.275-280, 2007 (SCI-Expanded) identifier identifier

Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26)

Akalin I., KUTLAY N., İLHAN ., Tukun A.
International Journal of Laboratory Hematology , cilt.29, sa.3, ss.215-220, 2007 (SCI-Expanded) identifier identifier

Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra

SOYDAN E., Ayyildiz E., DALVA K., TOPÇUOĞLU P., BAY M., ARSLAN Ö., et al.
Transfusion and Apheresis Science , cilt.36, sa.3, ss.269-273, 2007 (SCI-Expanded) identifier identifier

The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)

Ayyildiz E., ARSLAN Ö., TOPÇUOĞLU P., Arat M., DALVA K., SOYDAN E., et al.
Transfusion and Apheresis Science , cilt.36, sa.1, ss.79-85, 2007 (SCI-Expanded) identifier identifier

Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases

YÜCESAN C., Arslan Ö., Arat M., Yücemen N., Ayyildiz E., İLHAN ., et al.
Transfusion and Apheresis Science , cilt.36, sa.1, ss.103-107, 2007 (SCI-Expanded) identifier identifier

Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates

Büyükkaǧnici D. I., İLHAN ., Kavas G. Ö., ARSLAN Ö., Arat M., DALVA K., et al.
Transfusion and Apheresis Science , cilt.36, sa.1, ss.73-78, 2007 (SCI-Expanded) identifier identifier

Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?

Bakanay S. M., DALVA K., Arat M., ARSLAN Ö., Ayyildiz E., Beksac M., et al.
Transfusion and Apheresis Science , cilt.34, sa.2, ss.171-178, 2006 (SCI-Expanded) identifier identifier

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission

Tallman M. S., Pérez W. S., Lazarus H. M., Gale R. P., Maziarz R. T., Rowe J. M., et al.
Biology of Blood and Marrow Transplantation , cilt.12, sa.2, ss.204-216, 2006 (SCI-Expanded) identifier identifier

Expression of IFITM1 in chronic myeloid leukemia patients

Akyerli C. B., Beksac M., Holko M., Frevel M., DALVA K., Özbek U., et al.
Leukemia Research , cilt.29, sa.3, ss.283-286, 2005 (SCI-Expanded) identifier identifier

High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation

DEMİRER T., Ayli M., Fen T., ÖZCAN M. E., Arat M., Buyukberber S., et al.
Bone Marrow Transplantation , cilt.34, sa.9, ss.781-786, 2004 (SCI-Expanded) identifier identifier

Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

İLHAN ., Arat M., ARSLAN Ö., Ayyildiz E., Sanli H., Beksac M., et al.
Transfusion and Apheresis Science , cilt.30, sa.3, ss.185-187, 2004 (SCI-Expanded) identifier identifier

Transfusion and Apheresis Science: Introduction

İLHAN .
Transfusion and Apheresis Science , cilt.30, sa.3, ss.179-180, 2004 (SCI-Expanded) identifier

Therapeutic plasma exchange in a single center: Ibni Sina experience

ARSLAN Ö., Arat M., Tek I., Ayyildiz E., İLHAN .
Transfusion and Apheresis Science , cilt.30, sa.3, ss.181-184, 2004 (SCI-Expanded) identifier identifier

Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience

Arat M., ARSLAN Ö., Ayyildiz E., TOPÇUOĞLU P., DALVA K., İLHAN .
Transfusion and Apheresis Science , cilt.30, sa.3, ss.189-191, 2004 (SCI-Expanded) identifier identifier

Simultaneous Onset of Chronic Graft Versus Host Disease and Alopecia Areata Following Allogeneic Haematopoietic Cell Transplantation [11]

ŞANLI H., Kusak F., Arat M., Ekmekci P., İLHAN .
Acta Dermato-Venereologica , cilt.84, sa.1, ss.86-87, 2004 (SCI-Expanded) identifier identifier

Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure

Tek I., ARSLAN Ö., Arat M., Ayyildiz E., BAY M., Oral M., et al.
Transfusion and Apheresis Science , cilt.31, sa.2, ss.89-93, 2004 (SCI-Expanded) identifier identifier

The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy

Arat M., ARSLAN Ö., Gürman G., DALVA K., ÖZCAN M., Uǧur A., et al.
Transfusion and Apheresis Science , cilt.30, sa.1, ss.9-15, 2004 (SCI-Expanded) identifier identifier

Role of pretransplant interferon-α(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): Results from three Turkish transplant centers

Beksac M., Çelebi H., Sargín D., Yalcin A., Topcuoglo P., Kalayoglu-Besisik S., et al.
Bone Marrow Transplantation , cilt.31, sa.10, ss.897-904, 2003 (SCI-Expanded) identifier identifier

High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: A retrospective evaluation

DEMİRER T., Uysal V., Ayli M., Genc Y., İLHAN ., Koc H., et al.
Bone Marrow Transplantation , cilt.31, sa.9, ss.755-761, 2003 (SCI-Expanded) identifier identifier

The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia

KUTLAY S., Beksac M., DALVA K., İLHAN ., Koc H., Akan H., et al.
Leukemia and Lymphoma , cilt.44, sa.5, ss.791-795, 2003 (SCI-Expanded) identifier identifier

Effects of replacement fluids on coagulation system used for therapeutic plasma exchange

Tek I., ARSLAN Ö., Arat M., ÖZCAN M., Akdaǧ B., İLHAN .
Transfusion and Apheresis Science , cilt.28, sa.1, ss.3-7, 2003 (SCI-Expanded) identifier identifier

Malpositioning of Hickman catheters, left versus right sided attempts

ÜNAL A. E., BAYAR S., Arat M., İLHAN .
Transfusion and Apheresis Science , cilt.28, sa.1, ss.9-12, 2003 (SCI-Expanded) identifier identifier

Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse

Lee S. J., Klein J. P., Barrett A. J., Ringden O., Antin J. H., Cahn J., et al.
Blood , cilt.100, sa.2, ss.406-414, 2002 (SCI-Expanded) identifier identifier

An unusual presentation of plasma cell dyscrasias: Cardiac tamponade due to myelomatous infiltration

Arat M., Ulusoy V., DEMİRER T., Uysal A. V., ÖZCAN M., Dinçer S., et al.
Leukemia and Lymphoma , cilt.43, sa.1, ss.145-148, 2002 (SCI-Expanded) identifier identifier

A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

DEMİRER T., Dagli M., İLHAN ., Ayli M., Haznedar R., Fen T., et al.
Bone Marrow Transplantation , cilt.29, sa.11, ss.893-897, 2002 (SCI-Expanded) identifier identifier

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Üstün C., Beksac M., DALVA K., Koc H., Konuk N., İLHAN ., et al.
Medical Oncology , cilt.19, sa.1, ss.59-67, 2002 (SCI-Expanded) identifier identifier

Effects of DMSO on platelet functions and P-Selectin expression during storage

Cetin M., Eser B., Er Ö., ÜNAL A., KILIÇ E., Patiroglu T., et al.
Transfusion and Apheresis Science , cilt.24, sa.3, ss.261-267, 2001 (SCI-Expanded) identifier identifier

The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation

Gürman G., Dilek I., ARSLAN Ö., Arat M., Beksaç M., İLHAN ., et al.
Transfusion and Apheresis Science , cilt.24, sa.1, ss.23-28, 2001 (SCI-Expanded) identifier identifier

Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRA.

Ustün C., Arat M., Celebi H., Akan H., İLHAN ., Ozçelik T., et al.
Haematologica , cilt.86, sa.10, 2001 (SCI-Expanded) identifier identifier

CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

DEMİRER T., İLHAN ., Arat M., YAVUZ Y., ÖZCAN M. E., DALVA K., et al.
Journal of Clinical Apheresis , cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded) identifier identifier

Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue [4]

Arat M., İLHAN ., Iayan E. A., Çelebl H., Koç H., Akan H.
Blood , cilt.98, sa.3, ss.892-893, 2001 (SCI-Expanded) identifier identifier

Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

ÖZCAN M. E., Üstün C., Akçağlayan E., Akan H., ARSLAN Ö., İLHAN ., et al.
Bone Marrow Transplantation , cilt.27, sa.5, ss.499-505, 2001 (SCI-Expanded) identifier identifier

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies

Gürman G., Arat M., İLHAN ., Konuk N., Beksaç M., ÇELEBİ H., et al.
Cytotherapy , cilt.3, sa.4, ss.253-260, 2001 (SCI-Expanded) identifier identifier

Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-α-2a treatment

Beksa M., Arat M., Akan H., Ko H., İLHAN ., ÖZCAN M.
Cancer , cilt.89, sa.7, ss.1474-1481, 2000 (SCI-Expanded) identifier identifier

Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: Experience of Ibni Sina Hospital

ARSLAN Ö., COŞKUN H., Arat M., ÇELEBİ H., ÖZCAN M. E., Gürman G., et al.
Bone Marrow Transplantation , cilt.25, sa.12, ss.1229-1232, 2000 (SCI-Expanded) identifier identifier

Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF

ARSLAN Ö., Akan H., Arat M., DALVA K., ÖZCAN M. E., Gurman G., et al.
Cytotherapy , cilt.2, sa.4, ss.259-265, 2000 (SCI-Expanded) identifier identifier

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

DEMİRER T., İLHAN ., Mandel N., Arat M., Günel N., ÇELEBİ H., et al.
Bone Marrow Transplantation , cilt.25, sa.7, ss.697-703, 2000 (SCI-Expanded) identifier identifier

Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations [4] (multiple letters)

Reddy V., Khan S., Wingard J., Mehta P., Marsh J., Schrezenmeier H., et al.
Blood , cilt.94, sa.5, ss.1833-1834, 1999 (SCI-Expanded) identifier identifier

Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European blood and marrow transplant (EBMT) severe aplastic anaemia working party

Marsh J., Schrezenmeier H., Marin R., İLHAN ., Ljungman P., McCann S., et al.
Blood , cilt.93, sa.7, ss.2191-2195, 1999 (SCI-Expanded) identifier identifier

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

İLHAN ., ARSLAN Ö., Arat M., Beksaç M., Akan H., Özean M., et al.
Transfusion Science , cilt.20, sa.1, ss.69-71, 1999 (SCI-Expanded) identifier identifier

Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe

Üstün C., İDİLMAN R., Gürman G., ÖZCAN M., AKYOL G., Akan H., et al.
Journal of Hepatology , cilt.31, sa.2, ss.202-209, 1999 (SCI-Expanded) identifier identifier

Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation

DEMİRER T., ÇELEBİ H., Arat M., Üstün C., DEMİRER S., Dilek I., et al.
Bone Marrow Transplantation , cilt.24, sa.3, ss.335-337, 1999 (SCI-Expanded) identifier identifier

Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey

ARSLAN Ö., Gürman G., Dilek I., ÖZCAN M., Koç H., İLHAN ., et al.
Haematologia , cilt.29, sa.1, ss.59-62, 1998 (SCI-Expanded) identifier identifier

Resistant graft failure overcome with allogeneic peripheral blood plus bone marrow stem cells

ARSLAN Ö., Seferoǧlu A., Gürman G., İLHAN ., Koç H.
Haematologia , cilt.29, sa.1, ss.47-50, 1998 (SCI-Expanded) identifier identifier

Allogeneic peripheral blood stem cell transplantation in acute non- lymphoblastic leukemia

ARSLAN Ö., Üstün C., Arat M., Çelebi H., Akan H., Beksaç M., et al.
Hematological Oncology , cilt.16, sa.4, ss.155-162, 1998 (SCI-Expanded) identifier identifier

Serum erythropoietin levels in patients with leukemia on cytostatic treatment

Aydogdu I., İLHAN ., Beksac M., Koc H., Akan H., Konuk N., et al.
Haematologia , cilt.29, sa.2, ss.133-137, 1998 (SCI-Expanded) identifier identifier

Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia

Dilek I., DEMİRER T., Üstün C., Arat M., Koç H., Beksaç M., et al.
Bone Marrow Transplantation , cilt.21, sa.11, ss.1159-1161, 1998 (SCI-Expanded) identifier identifier

Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma

Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.
Haematologia , cilt.28, sa.4, ss.207-213, 1997 (SCI-Expanded) identifier identifier

A case report of a patient who has pure red cell aplasia and rheumatoid arthritis

Üstün C., Karavelioǧlu D., İLHAN ., Aydintuǧ O., Beksaç M.
International Journal of Hematology , cilt.66, sa.4, ss.505-512, 1997 (SCI-Expanded) identifier identifier

Hepatitis B virus infection in allogeneic bone marrow transplantation

Üstün C., Koç H., Karayalçin S., AKYOL G., Gürman G., İLHAN ., et al.
Bone Marrow Transplantation , cilt.20, sa.4, ss.289-296, 1997 (SCI-Expanded) identifier identifier

Febrile neutropenia in a bone marrow transplantation unit

Akan H., Koç H., ARSLAN Ö., Beksaç M., İLHAN ., Gürman G., et al.
International Journal of Antimicrobial Agents , cilt.8, sa.2, ss.127-130, 1997 (SCI-Expanded) identifier identifier

Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients?

Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., Dilek I., Akan H., et al.
Journal of Chemotherapy , cilt.9, sa.5, ss.371-376, 1997 (SCI-Expanded) identifier identifier

Hemorrhagic cystitis as a complication of bone marrow transplantation

İLHAN ., Koç H., Akan H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.
Journal of Chemotherapy , cilt.9, sa.1, ss.56-61, 1997 (SCI-Expanded) identifier identifier

Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support

Koç H., ARSLAN Ö., Gürman G., Akan H., ÖZCAN M., İLHAN ., et al.
Acta Haematologica , cilt.98, sa.3, ss.136-139, 1997 (SCI-Expanded) identifier identifier
Diğer Dergilerde Yayınlanan Makaleler

Lenfoplazmasitik Lenfomada Yeni Nesil Dizileme Yöntemiyle Mutasyon İncelemesinin Tanı ve Tedavi Planında Yeri

KOYUN D., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., TOPÇUOĞLU P., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.8, sa.1, ss.39-45, 2024 (Hakemli Dergi) Creative Commons License identifier

Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Aseptik Nekroz Gelişen Olgularda Vitamin D Reseptör Gen Polimorfizmi

SOYDAN E., ŞAHİN U., CEYLANER S., GÖKMEN A., DOĞAN H., OKCU M. K., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.7, sa.2, ss.51-56, 2023 (Hakemli Dergi) Creative Commons License identifier

İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi

KIRCALI E., SEVAL G. C., ÖZTÜRK C., Yilmaz H., ŞENOYMAK M. C., ERMİŞ G. Y., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.6, sa.2, ss.50-55, 2022 (Hakemli Dergi) Creative Commons License identifier

Lipoprotein apheresis efficacy and challenges: single center experience

Özdemir Z. N., Şahin U., Yıldırım Y., TULUNAY KAYA C., İLHAN .
Hematology, Transfusion and Cell Therapy , cilt.44, sa.1, ss.56-62, 2022 (ESCI) identifier identifier

Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings

Soto-Perez-de-Celis E., Martínez-Peromingo J., Chávarri-Guerra Y., Loh K. P., Demichelis-Gómez R., Rodrigues M., et al.
The Lancet Healthy Longevity , cilt.2, sa.11, 2021 (ESCI) identifier identifier

Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis

Karadag F. K., YENEREL M. N., YILMAZ M., uskudar T. H., ÖZKOCAMAN V., Tuglular T., et al.
American journal of Blood Research , cilt.11, sa.3, ss.279-285, 2021 (Hakemli Dergi)

Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi

KOYUN D., SEVAL G. C., SÖKMEN M., AKKUŞ E., ATİLLA E., BOZDAĞ S. C., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.5, sa.1, ss.1-4, 2021 (Hakemli Dergi) Creative Commons License identifier

Trombositozlu Olgularda Terapötik Trombosit Aferezinin Etkinliği

ÖZDEMİR Z. N., ŞAHİN U., BOZDAĞ S. C., YÜKSEL M. K., TOPRAK S. K., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.74, sa.3, ss.278-282, 2021 (Hakemli Dergi) identifier

Bir Nakil Merkezinin 11 YıllıkAllojeneik Kök Hücre Nakli Deneyimi

KIRCALI E., SEVAL G. C., BOZDAĞ S. C., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.50-54, 2020 (Hakemli Dergi) Creative Commons License identifier

Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.2, ss.113-117, 2020 (Hakemli Dergi)

Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.2, ss.113-117, 2020 (Hakemli Dergi) identifier

Miyelodisplastik Sendrom HastalarınınAkan Hücre Ölçer ile Yapılan OgataSkorlaması Yoluyla Değerlendirilmesi:Pilot Çalışma

ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.45-49, 2020 (Hakemli Dergi) identifier

Our Approach in Allogeneic Stem CellTransplantation: 11 Years of Experience

Kırcalı E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.50-54, 2020 (Hakemli Dergi)

Evaluation of Patients With Myelodysplastic Syndromeby Ogata Scoring in Flow Cytometry: Pilot Study

ATİLLA E., Kırcalı E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.45-49, 2020 (Hakemli Dergi)

Our Treatment Approach to Hairy Cell Leukemia

ATACA ATİLLA P., ATİLLA E., KIRCALI E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (Hakemli Dergi)

Tüylü Hücreli Lösemide Tedavi Yaklaşımımız

ATACA ATİLLA P., ATİLLA E., Kırcalı E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (Hakemli Dergi) identifier

Impact of Hepatitis B Core Antibody Seropositivity on the Liver Function Tests After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.3, ss.55-59, 2019 (Hakemli Dergi)

MULTİPLE MYELOMA HASTALARINDA ORTA DOZ SİKLOFOSFOMİD (2.5g /m2 Cy) İLE HEMATOPOETİK KÖK HÜCRE MOBİLİZASYONU SONUÇLARIMIZ

GÖKGÖZ Z., SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.
İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , cilt.23, sa.3, ss.184-189, 2019 (Hakemli Dergi) identifier

The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.9-13, 2019 (Hakemli Dergi)

Akut Lösemide Allojeneik Nakil Öncesi Serum Ferritin Düzeyinin Nakil Sonuçlarına Etkisi

ŞAHİN U., HASAN E., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.1-3, 2019 (Hakemli Dergi)

Kronik Lenfositik Lösemi’de Tanı Anında Hipogammaglobulinemi Sağkalım ve Enfeksiyon Riski Üzerine Etklili Midir?

ATİLLA E., Özel F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, 2018 (Hakemli Dergi) identifier

Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., DALVA K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.4, ss.93-97, 2018 (Hakemli Dergi)

Primer Mediastinal Büyük B Hücreli Lenfoma Hastalarımızın Tedavi Sonuçlarının Geriye Dönük Değerlendirilmesi

ATİLLA E., ATACA ATİLLA P., CENGİZ SEVAL G., TOPRAK S. K., İLHAN O., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.3, 2018 (Hakemli Dergi)

KRONİK LENFOSİTİK LÖSEMİ’DE TANI ANINDAHİPOGAMMAGLOBULİNEMİSAĞKALIM VE ENFEKSİYON RİSKİ ÜZERİNDE ETKİLİ MİDİR?

ATİLLA E., ÖZEL F., ATACA ATİLLA P., TOPÇUOĞLU P., AKAN H., BEKSAÇ M., et al.
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.294-299, 2018 (Hakemli Dergi)

Investigating the Presence of Chronic Myeloid Leukemia Leukemic Stem Cells (CML LSCs) in Patients with Tyrosine Kinase Inhibitors Who Achieved Cytogenetic / Molecular Response

NARLI ÖZDEMİR Z., USLU A., TOPRAK S. K., TOPÇUOĞLU P., DALVA K., İLHAN O.
Hematological Disease and Therapies , 2018 (Hakemli Dergi)

Kronik Lenfositik Lösemi’de Allojeneik Kök Hücre Nakli Deneyimi

ATİLLA E., PEKCAN G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.71, sa.1, ss.43-46, 2018 (Hakemli Dergi) identifier

Allogeneic Stem Cell Transplantation Experience in Chronic Lymphocytic Leukemia

ATİLLA E., Pekca G., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.71, sa.1, ss.43-46, 2018 (Hakemli Dergi)

Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , cilt.11, sa.1, ss.13-17, 2018 (Scopus)

Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience

Atilla P. A., Atilla E., Bozdag S. C., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Hematology/ Oncology and Stem Cell Therapy , cilt.11, sa.1, ss.13-17, 2018 (Scopus) identifier identifier

Multiple Arterial Thrombosis Related with Cantharidin Ingestion

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., İLHAN O.
CASE REPORTS IN HEMATOLOGY , cilt.2018, sa.8159093, ss.1-3, 2018 (Hakemli Dergi) identifier

Clinical characteristics and treatments outcomes in elderly patients with multiple myeloma: A multicenter retrospective study

TERZİ H., KORKMAZ S., BERBER İ., KEKLİK M., DOĞU M. H., ŞENCAN M., et al.
Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.39, sa.1, ss.389-395, 2017 (Hakemli Dergi) identifier

Kök hücre nakli hastalarında tamamlayıcı ve alternatif tedavi kullanımı

KARACAN Y., AKKUŞ Y., AKDEMİR N., GÖKER H., AKSU S., SUCAK A. G., et al.
Uludağ Üniversitesi Tıp Fakültesi Dergisi , cilt.38, sa.1, ss.1-6, 2012 (Hakemli Dergi) identifier

The impact of levobupivagaine and bupivacaine on postoperative respiratory functions and pain management in thoracic epidural analgesia Bupivakain ve levobupivakain'in torakal epidural uygulamalarinda postoperatif solunum fonksiyonlari ve aǧri üzerine etkileri

Serin G., Göksu S., Koruk S., Şahin L., Gül R., İLHAN ., et al.
Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi , cilt.16, sa.3, ss.96-102, 2010 (Scopus) identifier

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation

ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., ARAT M., İLHAN O.
Turkish Journal of Hematology , cilt.27, sa.2, ss.91-98, 2010 (Scopus) identifier identifier identifier

Dexmedetomidine in the supratentorial craniotomy

İLHAN O., KORUK S., SERİN G., ERKUTLU İ., ÖNER Ü.
Eurasian Journal of Medicine , cilt.42, sa.2, ss.61-65, 2010 (Hakemli Dergi) identifier

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation Allogeneik hematopoietik hücre nakli sonrası sklerodermatoz tip graft-versus-host hastalıǧının klinik yönleri

ŞANLI H., AKAY B. N., SOYDAN E., KOÇYİĞİT P., Arat M., İLHAN .
Turkish Journal of Hematology , cilt.27, sa.2, ss.91-98, 2010 (Scopus) identifier identifier

Retrospective evaluation of patients treated with dasatinib for Philadelphia positive leukemias: Turkish experience of 16 months

Saydam G., Haznedaroglu I. C., Temiz Y., Soysal T., Sucak G., Tombuloglu M., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.19, sa.4, ss.195-204, 2009 (Scopus) identifier identifier

Clonal evolution of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation

Bakanay Ş. M., TOPÇUOĞLU P., Bilgin A. U., Yararbaş K., Karaüzüm S. B., ÖZCAN M., et al.
Turkish Journal of Hematology , cilt.25, sa.2, ss.94-97, 2008 (Scopus) identifier identifier

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience

İLHAN ., TOPÇUOĞLU P., Arat M., SOYDAN E., YÜKSEL M., ARSLAN Ö., et al.
Turkish Journal of Hematology , cilt.25, sa.2, ss.87-93, 2008 (Scopus) identifier identifier

Therapeutic angiogenesis by autologous transplantation of bone-marrow mononuclear cells for Buersger's patients with retractable limb ischaemia: A preliminary report

AKAR A. R., Durdu S., Arat M., Eren N. T., ARSLAN Ö., Çorapçioǧlu T., et al.
Turkish Journal of Haematology , cilt.21, sa.1, ss.13-21, 2004 (Scopus) identifier

Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange

ARSLAN Ö., Tek I., Arat M., ÇİFTCİ İ., İLHAN .
Therapeutic Apheresis and Dialysis , cilt.8, sa.2, ss.144-147, 2004 (Scopus) identifier identifier

Autologous platelet collection and storage to support thrombocytopenia in a leukemia patient with platelet alloimmunization undergoing chemotherapy

YÜKSEL M., Arat M., ARSLAN Ö., Beksaç M., İLHAN .
Turkish Journal of Haematology , cilt.20, sa.4, ss.233-236, 2003 (Scopus) identifier

Clinical use of erythropoietin in patients with anemia due to radiotherapy Radyoterapi̇ alan anemi̇k hastalarda eri̇tropoeti̇n'i̇n kli̇ni̇k kullanimi

ALTUNTAŞ F., Arat M., İLHAN .
Erciyes Tip Dergisi , cilt.25, sa.1, ss.45-53, 2003 (Scopus) identifier

Therapeutic plasma exchange and the clinical applications

ARSLAN Ö., Arat M., Göktürk S., Ayyildiz E., İLHAN .
Turkish Journal of Haematology , cilt.20, sa.1, ss.7-17, 2003 (Scopus) identifier

The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation

ARSLAN Ö., Coşkun H. Ş., Arat M., SOYDAN E., ÖZCAN M., Gürman G., et al.
Turkish Journal of Haematology , cilt.19, sa.3, ss.401-409, 2002 (Scopus) identifier identifier

Extramedullary presentation of biclonal IgGκ and IgAκ multiple myeloma

Alanoǧlu G., Özet G., DALVA K., KUZU I., Erekul S., İLHAN ., et al.
Turkish Journal of Haematology , cilt.19, sa.3, ss.421-425, 2002 (Scopus) identifier

Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield

DEMİRER T., İLHAN ., Ayli M., Arat M., Dagli M., ÖZCAN M., et al.
Therapeutic Apheresis , cilt.6, sa.5, ss.384-389, 2002 (Scopus) identifier identifier

Influence of storage time on activation of platelets collected with CS 3000 Plus and Cobe Spectra using platelet storage containers

KUTLAY S., İLHAN ., ARSLAN Ö., Beksac M.
Therapeutic Apheresis , cilt.6, sa.1, ss.82-85, 2002 (Scopus) identifier identifier

A case of catheter related septicemia caused by Corynebacterium jeikeium

Arikan Akan Ö., Bengisun J. S., Bati A., Arat M., İLHAN ., Akan H.
Turkish Journal of Haematology , cilt.19, sa.1, ss.47-50, 2002 (Scopus) identifier identifier

Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia

Gürman G., ÇELEBİ H., Üstün C., Arat M., İLHAN ., ÖZCAN M. E., et al.
Therapeutic Apheresis , cilt.5, sa.1, ss.54-57, 2001 (Scopus) identifier identifier

Severe hypotensive reaction due to a bedside white cell reduction filter

ARSLAN Ö., Elkiran T., Arat M., İLHAN ., Koç H.
Turkish Journal of Haematology , cilt.18, sa.1, ss.59-61, 2001 (Scopus) identifier identifier

Treatment of aplastic anemia: Experience of Ibn-i Sina Hospital

İLHAN ., Bakanay Ş., Arat M., ÖZCAN M. E., ÇELEBİ H., Gürman G., et al.
Turkish Journal of Haematology , cilt.18, sa.1, ss.33-40, 2001 (Scopus) identifier identifier

Multiple myeloma: Current approach Multi̇pl myeloma: Güncel yaklaşimlar

Coşkun H., Er Ö., İLHAN .
Erciyes Tip Dergisi , cilt.23, sa.2, ss.83-90, 2001 (Scopus) identifier

The incidence of Hepatitis G virus in patients with hematological malignancies: The relationship to the number of blood and blood products transfusions

Idilman R., Ustun C., Aslan O., Ozcan M., Arat M., Bozkaya H., et al.
Turkish Journal of Haematology , cilt.17, sa.2, ss.67-71, 2000 (Scopus) identifier identifier

National survey of hemapheresis practice in Turkey (1998)

İLHAN ., üskent N., ARSLAN Ö., Arat M., ÖZKALEMKAŞ F., öztürk G., et al.
Transfusion and Apheresis Science , cilt.22, sa.3, ss.195-201, 2000 (Scopus) identifier identifier

Immunosuppressive therapy-induced hepatotoxicity in patients with aplastic anemia

Dilek I., İDİLMAN R., Fenkci S., Ustun C., Koc H., İLHAN ., et al.
Turkish Journal of Haematology , cilt.17, sa.3, ss.111-117, 2000 (Scopus) identifier identifier

Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report

Üstün C., Çelebi H., Arat M., ÖZCAN M., Dilek I., Gürman G., et al.
Therapeutic Apheresis , cilt.3, sa.3, ss.275-277, 1999 (Scopus) identifier identifier

Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease

Üstün C., ÖZCAN M., Gürman G., Çakir M., Erekul S., AKYOL G., et al.
Pathology and Oncology Research , cilt.5, sa.3, ss.229-232, 1999 (Scopus) identifier identifier

Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia

Beksaç M., ARSLAN Ö., Koç H., Akan H., İLHAN ., Arat M., et al.
Medical Oncology , cilt.15, sa.3, ss.183-190, 1998 (Scopus) identifier identifier

Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey

İLHAN ., Akan H., Koç H., Gürman G., ARSLAN Ö., ÖZCAN M. E., et al.
Hematology and Cell Therapy , cilt.39, sa.3, ss.133-136, 1997 (Scopus) identifier identifier

Evaluation of saturation index of lymphoma patients

ÇOK İ., Karakaya A., Sardas S., İLHAN ., Koc H.
Gazi Universitesi Eczacilik Fakultesi Dergisi , cilt.14, sa.1, ss.5-10, 1997 (Scopus) identifier

Administration of mine protocol in intermediate and high grade non- Hodkin's lymphomas Primejena Protokola mine u lijecenju nehodgikinovih limfona srednjeg i visokog stupnja

Aydogdu I., Koc H., İLHAN ., Gurman G., Akan H., Beksac M., et al.
Libri Oncologici , cilt.25, sa.2-3, ss.103-106, 1996 (Scopus) identifier

Lack of prognostic value of CD34 in adult AML.

Arslan O., Akan H., Beksac M., Ozcan M., Koc H., İLHAN ., et al.
Leukemia & lymphoma , cilt.23, sa.1-2, ss.185-186, 1996 (Scopus) identifier identifier

Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation? [6]

Koc H., Gurman G., ARSLAN Ö., ÖZCAN M. E., Akan H., İLHAN ., et al.
Blood , cilt.88, sa.6, ss.2362-2364, 1996 (Scopus) identifier identifier

A single center randomized study comparing the efficacy of sulbactam/cefoperazone + amikacin vs ceftazidim + amikacin in febrile neutropenic patients FEBRIL NOTROPENIK HASTALARDA TEK MERKEZLI RANDOMIZE BIR CALISMADA SULBAKTAM/SEFOPERAZON + AMIKASIN ILE SEFTAZIDIM + AMIKASIN ETKINLIGININ KARSILASTIRILMASI

Akan H., Koc H., Aydogdu I., İLHAN ., Beksac M., Gurman G., et al.
Mikrobiyoloji Bulteni , cilt.29, sa.2, ss.131-135, 1995 (Scopus) identifier

HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapy [4]

İLHAN ., Beksac M., Koc H., Akan H., Keskin A., ARSLAN Ö., et al.
Blood , cilt.86, sa.5, ss.2055, 1995 (Scopus) identifier identifier

P53 codon 213 (a-g) polymorphism in a turkish population

Ilhan I., Erekul S., Ateşalp S., İLHAN ., Akar N.
Pediatric Hematology and Oncology , cilt.12, sa.5, ss.499-501, 1995 (Scopus) identifier identifier

Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia [1]

Gurman G., Kahveci G., Akan H., İLHAN ., Koc H., Beksac M., et al.
Bone Marrow Transplantation , cilt.15, sa.3, ss.485-486, 1995 (Scopus) identifier identifier

Relevance of serum G-CSF levels in bone marrow transplantation patients [1]

Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN .
Experimental Hematology , cilt.22, sa.6, ss.480-481, 1994 (Scopus) identifier identifier

Terminal deoxynucleotidyl transferase (TdT) positivity in acute nonlymphoblastic leukemia [1]

ARSLAN Ö., Akan H., Beksac M., İLHAN ., Koc H., Konuk N.
Leukemia , cilt.8, sa.6, ss.1067, 1994 (Scopus) identifier identifier

Peripheral T cell receptors αβ, and γδ in patients with Hodgkin's lymphoma

Akan H., Beksac M., Aydogdu I., Koc H., İLHAN ., Ozcan M.
British Journal of Haematology , cilt.87, sa.3, ss.544-547, 1994 (Scopus) identifier identifier

Cyclosporin A (CsA) + methylprednisone (MP) and antilymphocyte globulin + methylprednisone (MP) therapy in patients with aplastic anemia: Ibn-i Sina Hospital experience

İLHAN ., Koc H., Beksac M., Akan H., Aydogdu I., Konuk N., et al.
Bulletin of Gulhane Military Medical Academy , cilt.35, sa.4, ss.893-897, 1993 (Scopus) identifier

The clinical correlations of serum tumor necrosis factor-alpha in acute leukemias: A predictor of response and relapse?

Beksaç M., ERTÜRK Ş., Akan H., Koç H., İLHAN .
Leukemia , cilt.7, sa.11, ss.1773-1776, 1993 (Scopus) identifier identifier

Circulating endogenous granulocyte colony-stimulating factor levels after bone marrow transplantation [4]

Beksac M., ÖZCAN M. E., Koc H., Akan H., İLHAN ., Sardas O., et al.
Blood , cilt.80, sa.11, ss.2946-2947, 1992 (Scopus) identifier identifier

Use of high dose chemotherapy and autologous bone marrow transplantation in patients with intermediate or high grade NHL both as a consolidation after remission or in early relapse

Sardas O., Koc H., İLHAN ., Akan H., Beksac M.
Istanbul Tip Fakultesi Mecmuasi , cilt.54, sa.4, ss.567-574, 1991 (Scopus) identifier

Polymorphic N‐acetylation capacity in breast cancer patients

Şardş S., ÇOK İ., Seyfişardaş O., İLHAN ., Karakaya A. E.
International Journal of Cancer , cilt.46, sa.6, ss.1138-1139, 1990 (Scopus) identifier identifier

Tumor necrosis factor α in human bone marrow recipients

Sardas O., Beksac M., Koc H., İLHAN ., Akan H., Gurman G.
Blood , cilt.76, sa.12, ss.2639, 1990 (Scopus) identifier identifier

Hepatic failure after bone marrow transplantation (I)

Sardas O., Koc H., İLHAN ., Akan H., Beksac M.
Blood , cilt.75, sa.11, ss.2265, 1990 (Scopus) identifier identifier

A meningococcal epidemic in Ankara Ankara ilinde devam etmekte olan menengokoksk menenjit salgini.

Berkman E., Ozben G., İLHAN .
Mikrobiyoloji Bulteni , cilt.11, sa.2, ss.256-266, 1977 (Scopus) identifier identifier
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

the impact of pretransplant ımmunomodulatory drugs on cmv reactıvatıon

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., YAVUZ G., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 10 Ocak 2021

PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION

KIRCALI E., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
8th International Congress on Leukemia Lymphoma Myeloma, 21 Mayıs 2021

TİROZİN KİNAZ İNHİBİTÖRLERİNİ KESME KARARINDA KEMİKİLİĞİNDEKİ LÖSEMİK KÖK HÜCRE VARLIĞININ ÖNEMİ

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020

DECISION TO STOP TYROSINE KINASE INHIBITORS (TKIS) WITH BONE MARROW LEUKEMIC STEM CELL LEVEL: DETECTION OF BCR-ABL IN PERIPHERAL BLOOD MAY NOT BE ENOUGH

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
25th European Hematology Congress Virtual, 11 - 21 Haziran 2020

Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience

DEMİRER T., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 Mayıs - 02 Haziran 2020, cilt.38, ss.19522

A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm

ÖZCAN M., KOYUN D., CENGİZ SEVAL G., USLU A., KIRCALİ E., ÖZTÜRK C., et al.
2020 American Society of Clinical Oncology (ASCO) Annual Meeting, 29 Mayıs - 02 Haziran 2020

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Öztürk N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, Amerika Birleşik Devletleri, 19 - 23 Şubat 2020, cilt.26, ss.109-110

Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

İLHAN O., Seval G. C., UZAY A., KAYA E., Öztürk Z. N., DEVECİ B., et al.
Transplantation Cellular Therapy Meetings of ASTCT and CIBMTR, Amerika Birleşik Devletleri, 8 - 12 Şubat 2020, cilt.26, ss.191

Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre F., Ghulam J. M., Rena J B., Valeria S., Mara Dez C., Carlo F., et al.
ASH 2019, 7 - 10 Aralık 2019

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., USLU A., KIRCALI E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.
ASH 2019, 7 - 10 Aralık 2019

Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
ASH 2019, 7 - 10 Aralık 2019

Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy

Stephan S., Bosch F., Vronique L., İLHAN O., Jens K., Batrice M., et al.
ASH 2019, 7 - 10 Aralık 2019

Hematologic Improvement–Neutrophil and –Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Guillermo G., hulam J. M., Pierre F., Valeria S., Mara Dez C., Carlo F., et al.
ASH2019, 7 - 10 Aralık 2019

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., ÖZTÜRK N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
ASH 2019, 7 - 10 Aralık 2019

KRONİK MİYELOİD LOSEMİ (KML) HASTALARINDA KML KOKHUCRESİ BCR- ABL’DEN BAĞIMSIZ PROGNOSTİK BİR FAKTOR OLABİLİR Mİ?

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019

YENİ TANI KLL HASTALARINDA TANI SIRASINDAKİ CD49DEKSPRESYONUNUN HASTALIĞA OZGU BAŞKA PARAMETRELERLEİLİŞKİSİ

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019

Kronik Myeloid Lösemi (KML) Hastalarında KML Kök Hücresi BCR-ABL’ den Bağımsız Prognostik Bir Faktör Olabilir mi?

İLHAN O., NARLI ÖZDEMİR Z., ARSLAN A., OKAY M., İPEK Ş., DALVA K., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019

YAŞAM SÜRESİNİ VE KALİTESİNİ ETKİLEYEN DİRENÇLİ KGVHH TEDAVİSİNDE YENİ BİR YAKLAŞIMBTK İNHİBİTÖRÜ:GERÇEK YAŞAM VERİSİ

İLHAN O., Seval G. C., UZAY A., KAYA E., DEVECİ B., YAVAŞOĞLU İ., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019

TÜRKİYE’DE PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., ÖZDEMİR Z. N., ÖZET G., FALAY M., YENEREL M. N., TUĞLULAR A. T., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.131-132

TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., NARLI ÖZDEMİR Z., ÖZET G., falay m., YENEREL M. N., TUĞLULAR A. T., et al.
45. Ulusal Hematoloji Kongresi, Türkiye, 30 Ekim - 02 Kasım 2019

A retrospective single center experience with the generic of lenalidomide Rivelime (R) compared with original patented drug Revlimid (R)

BEKSAÇ M., CENGİZ SEVAL G., KOYUN D., TOPÇUOĞLU P., YÜKSEL M., GÜRMAN G., et al.
Lymphoma and Myeloma Congress 2019, 23 - 26 Ekim 2019

Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
17th International Myeloma Workshop, 12 - 15 Eylül 2019

Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 Mart 2019

Clonal Plasma Cell Detection by High Sensitive Flow Cytometry in Aphaeresis Product is Poor Prognostıc and not Increased by Use of Plerixafor Alone

CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.496-497 identifier identifier

Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT

YÜKSEL M., CENGİZ SEVAL G., KİRCİLİ E., D, K., ÖZTÜRK C., NARLI ÖZDEMİR Z., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), 24 - 27 Mart 2019

Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
45th Annual Meeting of the European Society for Blood and Marrow Transplantation, 24 - 27 Mart 2019

Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
24th Congress of the European Hematology Association, 13 - 16 Haziran 2019

Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 Haziran 2019

Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 1 - 03 Haziran 2019

Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., SEVAL G. C., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
ASCO, 31 Mayıs - 03 Haziran 2019

RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTS WITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTIC RELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE

CENGİZ SEVAL G., ULAŞ B. B., Bolat B., Taşçı O., Karatepe F., KUZU I., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019

LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019

PRE-TRANSPLANT HEMOGLOBIN AND SERUM CREATININE LEVELS CORRELATE WITH PROGRESSION FREE SURVIVAL IN MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019

CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION

YÜKSEL M., KIRCALI E., CENGİZ SEVAL G., KOYUN D., USLU A., ÖZTÜRK C., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019

LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTEMYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS -A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

SEVAL G. C., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019

CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019

retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
ICLLM 2019, 02 Mayıs 2019

RETROSPECTIVE ANALYSIS OF 149 UNSELECTED PATIENTSWITH MANTLE CELL LYMPHOMA CONFIRMS PROGNOSTICRELEVANCE OF MIPI: SINGLE CENTER EXPERIENCE

SEVAL G. C., ULAŞ B. B., bolat b., Taşçı O., karatepe f., KUZU I., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019

Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

KIRCALİ E., CENGİZ SEVAL G., KOYUN D., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., ÖZCAN M., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

Multiple Myelom Hastalarında Otolog Periferik Kök Hücre Nakli Esnasında Gelişen Nötropenik Ateş

USLU A., CENGİZ SEVAL G., ÖZTÜRK C., NARLI ÖZDEMİR Z., KIRCALİ E., KOYUN D., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

Allojeneik Kök Hücre Nakli Sonrası Akut Lösemi Hastalarında Nüksü Öngörmede Kimerizm İle Mrd Karşılaştırılması

CENGİZ SEVAL G., ULAŞ B. B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

İyi Riskli Aml’de İkinci Tam Remisyonda Allojeneik Hematopoietik Kök Hücre Nakli Tek Merkez Deneyimi

PEKCAN G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

POSTTRANSPLANT LENFOSİTOZ ÖNEMLİ BİR PARAMETRE MİDİR?

CENGİZ SEVAL G., USLU A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

T-All Hastalarında Allojeneik Hematopoetik Kök Hücre Nakli Sonrasında Nelarabin Tedavisi Graftı Kurtarabilir mi?

CENGİZ SEVAL G., USLU A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

Refrakter Akut Lösemili Hastalarda Ardışık Kurtarma Tedavisi İle Birlikte Ahkhn Yeterli Kür Sağlayabilir mi?

CENGİZ SEVAL G., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

Plerixafor, Periferik Kök Hücre Ürününde Akım Sitometri İle Saptanabilen Klonal Plazma Hücre Kontaminasyonunu Etkiler Mi?

CENGİZ SEVAL G., USLU A., DALVA K., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 02 Mart 2019, ss.74-75

Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019

Akut Miyeloid Lösemide Nakil Öncesi Minimal Kalıntı Hastalık Diğer Risk Faktörlerinden Daha Önemli Midir?

NARLI ÖZDEMİR Z., ŞAHİN U., BALTACI M. A., USLU A., ÖZTÜRK C., CENGİZ SEVAL G., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 02 Mart 2019, ss.76-77

Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019, cilt.25, ss.322

Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019

MİYELOM HASTALARINDA OHKHN ÖNCESİ KULLANILAN İLAÇLARIN CMV REAKTİVASYONU ÜZERİNE SAĞKALIMI AZALTICI ETKİSİ OLABİLİR Mİ?

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., ÖZTÜRK C., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019

CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019

Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019

Impact of ABO mismatch on outcomes of allogeneic hematopoietic stem cell recipients: 30 years of experience with 1016 patients.

ATİLLA E., TOPÇUOĞLU P., AKKUŞ E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
TCT Meetings of ASBMT and CIBMTR, February 20-24, 2019, Houston, Texas, USA. Biol Blood Marrow Transplant 201925(3):S322., 20 - 24 Şubat 2019

Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

SEVAL G. C., ATİLLA E., ULAŞ B. B., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 20 - 24 Şubat 2019, cilt.25, ss.176-177

İmmun Trombositopeni (İTP) hastalarında ABO kan gruplarının birinci basamak tedavi yanıtına etkisi

AKKUŞ E., FİDAN Ç., KUŞTAŞ A. A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
TKBD Uluslararası Katılımlı Hematolojik Hastalıkların Tanı Ve İzleminde Laboratuvar Sempozyumu, Türkiye, 5 - 07 Nisan 2018, cilt.16, ss.44

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF

DEMİRER T., AYLI M., ÖZCAN M., GÜNEL N., HAZNEDAR R., DAĞLI M., et al.
BRITISH JOURNAL OF HAEMATOLOGY, 1 Ocak - 30 Aralık 2018, cilt.116, ss.468-474 identifier identifier

Retrospective Analysis of 149 Unselected Patients with Mantle Cell Lymphoma Confirms Prognostic Relevance of Mantle Cell Lymphoma International Prognostic Index: Single Center Experience

SEVAL G. C., ULAŞ B. B., Taşçı O., Özel F., Bulat B., KUZU I., et al.
60th ASH Annual Meeting, San Diego, Amerika Birleşik Devletleri, 30 Kasım - 05 Aralık 2018

Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

TOPÇUOĞLU P., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.
60th ASH Annual Meeting, san diego, Amerika Birleşik Devletleri, 29 Kasım - 05 Aralık 2018, cilt.132, ss.5776

Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

GÜRMAN G., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
60th ASH Annual Meeting Exposition, san Diego, 29 Kasım - 04 Aralık 2018, cilt.132, ss.4673

Residual Clonal Plasma Cells Detected by Flow Cytometry at 10-4 Level within Autologous Stem Cell Grafts is Associated with Significantly Less Overall Survival

CENGİZ SEVAL G., DALVA K., BAKANAY S., MERTER M., ŞAHİN U., USLU A., et al.
60th American Society of Hematology Annual Meeting, San Diego, CA, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, ss.3438

Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

ATİLLA E., TOPÇUOĞLU P., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., DEMİRER T., et al.
60th ASH Annual Meeting, 30 Kasım - 05 Aralık 2018

The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4(+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect

YÜKSEL M., NARLI ÖZDEMİR Z., ŞAHİN U., ÇAĞDAŞ AYVAZ D. N., TURKUM ATIKCAN D., SERTESEN E., et al.
44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.533-534

İndüksiyon Mu Hazırlama Rejimi Mi Daha Önemli? İndüksiyon Sonrası Kalıntı Hastalığın Saptanamaması Bir Prognostik Gösterge Olabilir

CENGİZ SEVAL G., BAKANAY ÖZTÜRK Ş. M., MERTER M., ŞAHİN U., USLU A., NARLI ÖZDEMİR Z., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.161-162

Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan cd34 pozitif hücreler: Cd34 pozitif gen hematogonlara dikkat

DALVA K., Öz m. d., hakkoloğlu ş., avcu f., ERTEM M., İLHAN O., et al.
44. ulusal hematoloji kongresi, Türkiye, 31 Ekim - 03 Kasım 2018

ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018

Hematopoietik kök hücre nakli için toplanan kemik iliği materyallerinde sayılan Cd34 pozitif hücreler: CD34pozitif genç hematogonlara dikkat

DALVA K., Öz m. d., hakkoloğlu ş., ipek ş., öztürk a., taşkır f., et al.
44. ulusal hematoloji kongresi, Türkiye, 31 Ekim - 03 Kasım 2018

ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018

Promising utilization areas of theurapeutic plasmapheresis in cardiovascular surgery practice

DURDU M. S., ÇAKICI M., GÜMÜŞ F., ÇUBUKÇUOĞLU DENİZ G., CİVRİZ BOZDAĞ S., DİKMEN YAMAN N., et al.
Türk Kalp ve Damar Cerrahisi Derneği 15. Kongresi, Türkiye, 26 - 29 Ekim 2018, cilt.26

Yüksek PRA Düzeyi Olan Böbrek Nakli Alıcılarında Plazmaferez , IVIG ve Ritüksimab Tedavisinin Etkinliği

ORS SENDOGAN D., SARITAŞ H., KUMRU G., İLHAN O., TÜZÜNER A., KEVEN K., et al.
Ulusan Nefroloji, Hipertansiyon, Diyaliz ve tRansplantasyon Kongresi, Antalya, Türkiye, 3 - 07 Ekim 2018

AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUN NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018

Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience

Cengiz Seval G., BULAT B., Ozel F., Tasci O., Kuzu I., CİVRİZ BOZDAĞ S., et al.
ASCO Annual Meeting 2018, 1 - 05 Haziran 2018, cilt.36, ss.19525

Akut karaciğer yetmezliğinde plazmaferezin etkinliği

SANDAL S., ZEYBEK İ., TUNA KIRSAÇLIOĞLU C., ALTUNTAŞ C., DEMİR E., KENDİRLİ T., et al.
12.Ulusal Çocuk Gastroenteroloji, Hepatoloji ve BESLENME kONGRESİ, Türkiye, 18 - 21 Nisan 2018

Heparin enhances CD34 content of stem cells collected following G-CSF +/- chemotherapy

MERTER M., ŞAHİN U., YILDIRIM Y., İLHAN O., BEKSAÇ M.
44th Annual Meeting of European Society for Blood and Marrow Transplantation, Lizbon, Portekiz, 18 - 21 Mart 2018

Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen

İLHAN O., CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 Mart 2018

Impact of Hepatitis B Core Antibody Seopositivity on the Liver Function Tests after Autologous Hematopoietic Stem Cell Transplantation For Multiple Myeloma

CENGİZ SEVAL G., SERTESEN E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, 18 - 21 Mart 2018

BlastIc Plasmacyto Id DendrItIc Cell Neoplasm: SIngle CenterExperIence on a Rare Hematological Malignancy

NARLI ÖZDEMİR Z., SEVAL G. C., USLU A., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
5th Aegean Hematology Oncology Symphosium, Yunanistan, 23 Eylül 2018

Donor lymphocyte infusion after salvage chemotherapy inrelapsed acute myeloblastic leukemia patients afterallogeneic stem cell transplantation

USLU A., SEVAL G. C., CİVRİZ BOZDAĞ S., GÜRMAN G., DEMİRER T., ARSLAN Ö., et al.
The 44th Annual Meeting of the European Society for Blood andMarrow Transplantation: Physicians Poster Sessions, lizbon, Portekiz, 18 - 21 Mart 2018

ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI GELİŞENKARACİĞER SİNÜZOİDAL TIKANIKLIK SENDROM İNSİDANSIVE KLİNİK BULGULAR

GÜNDÜZ M., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
10. ULUSAL KEMİK İLİĞİTRANSPLANTASYONU VEHÜCRESEL TEDAVİLER KONGRESİ, Antalya, Türkiye, 1 - 03 Mart 2018

Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Akut Myeloid Lösemi Nüksünün Yönetimi ve Prognozu

ŞAHİN U., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., ÖZEN M., CİVRİZ BOZDAĞ S., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, ss.126-127

Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies

ARSLAN Ö., ELÇİN A. E., ATİLLA E., Şeker Ş., Baydın P., Gündüz M., et al.
ASBMT 2018, 21 - 25 Şubat 2018, cilt.24, ss.152-153

Ph Negatif ALL’de 1. Tam Remisyonda Yapılan Pekiştirme Tedavileri Nakil Sonrası Başarıyı Arttırır

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, ss.107-108

Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2018 BMT Tandem Meetings, 21 - 25 Şubat 2018, cilt.24, ss.140

Retrospective Analysis Learn Conditioning for Autologous Stem Cell Transplantation

SOYDAN E., GÖKMEN A., İLHAN O., ARSLAN Ö., ÖZCAN M.
Blood @marrow translant Res, 21 - 25 Şubat 2018

Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

ATİLLA E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.
American Society of Hematology, 8 - 12 Aralık 2017

Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

İLHAN O., Güldane C., TOPRAK S. K., TOPÇUOĞLU P., Özel F., CİVRİZ BOZDAĞ S., et al.
American Society of Hematology, 8 - 12 Aralık 2017

Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması

ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017

Hematolojik Maligniteli Hastalarda Haploidentik Kök Hücre Nakillerinde Mezenkimal Kök Hücre Uygulaması.

ARSLAN Ö., ELÇİN A. E., ATİLLA E., ŞEKER Ş., BAYDIN P., GÜNDÜZ M., et al.
43.ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 1 - 04 Kasım 2017

Engrafmanın Erken Belirteci: Büyük Boyanmamış Hücreler

Aydın T., MERTER M., ŞAHİN U., Pekcan G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.53

İmmun Trombositopenide (İTP) Yenilikler Işığında Klinik Retrospektif Değerlendirme: Tek Merkez Deneyimi

AKKUŞ E., KUŞTAŞ A. A., PEKCAN G., MERTER M., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.98-99

OTOLOG PERİFERİK KÖK HÜCRE NAKLİNDE KÖK HÜCRESAKLANMA SÜRESİ ENGRAFMAN SÜRESİNİ ETKİLER Mİ?

MERTER M., Güleç B., Özcan G., Zehra Özdemir Z., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.220

TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARINSIKLIĞININ SAPTANMASINA YÖNELİK ÇALIŞMA

İLHAN O., ÖZET G., FALAY M., YENEREL M. N., TURGUT M., ÜNAL A., et al.
43. Ulusal Hematoloji Kongresi, Türkiye, 1 - 05 Kasım 2017

Türkiye’den Çok Merkezli Erken Erişim Program Sonuçları: Daha Önce Yoğun Tedavi Almış Relaps/Refrakter Multipl Miyelom Hastalarında Daratumumabın Etkililik ve Güvenliliği

BEKSAÇ M., GOKER H., TURGUT M., AYDIN Y., BESİSİK S., Cagirgan S., et al.
Türk Hematoloji Derneği, Türkiye, 17 - 20 Ağustos 2017

Evaluating peritransplant albumin decline as a predictor of acute graft versus host disease

MERTER M., YÜKSEL M., demir e., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, ss.210-211 identifier identifier

The outcome of haploidentical hematopoietic celltransplantations

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52, ss.314

Peripheral blood stem cell mobilization and collectionfrom elderly patients (≥65 years) with multiple myeloma: Asingle center experience

seval g. c., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52

peripheral blood stem cell mobilization and collection from elderly patients with multiple myeloma:A single center experience

seval g., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
ebmt 2017, 26 - 29 Mart 2017

Allogeneic hematopoietic stem cell transplantation(allo-HSCT) in advanced age adults: is it possible totransplant safely?

ATİLLA E., baŞ o., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, cilt.52, ss.272-273

ALLOEGENEİC HEMATOPOİETİC STEM CELL TRANSPLANTATİON İN ADVANCED AGE ADULTS:İS İT POSSİBLE TO TRANSPLANT SAFELY?

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., AKAN H., et al.
ebmt2017, 26 - 29 Mart 2017

The outcome of haploidentical stem cell transplantation

ATİLLA E., bilgiç e., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
ebmt 2017, 22 - 25 Haziran 2017

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE

TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
22nd Congress of the European-Hematology-Association, 22 - 25 Haziran 2017

Autologous Stem Cell Trnasplantation for Mantle Cell Lymphoma: A Single Center Exprience

TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Exprience22nd Congress of the European Hematolgy Association, 22 Haziran - 25 Mayıs 2017

A single center experience with two decades of follow-up on patients with hairy cell leukemia.

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2 - 06 Haziran 2017

Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
53rd Annual Meeting, 2 - 06 Haziran 2017

Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantationd for acute myeloid leukemia

GÜRMAN G., AYDEMİR GULOKSUZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
leukemia53rd Annual Meeting, 2 - 06 Haziran 2017

Allojeneik stem cell transplantation results in our myelodysplastic sydrome (MDS) patientes

GÜRMAN G., ATACA ATİLLA P., AYDIN T., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
patientes53rd Annual Meeting Jun 2-6, 2017, 2 - 06 Haziran 2017

A single center experience With two decades of follow-up on patients With hairy cell leukemia

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
3rd Annual Meeting Jun 2-6, 2017, 2 - 06 Haziran 2017

Large Unstained Cell Percentage as a Predictor of Efficacious Peripheral Stem Cell Mobilization

MERTER M., KÖKEN K., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 Mayıs 2017

A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be

PEKCAN G., KURT YÜKSEL M., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Türkiye, 11 - 13 Mayıs 2017, ss.112

Evalauting peritransplant albümin decline as a predictor os acute graft versus host disease

MERTER M., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.
43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017

Allegeneic Hematopoetic Stem Cell Trnasplantation (Allo-HSCT) in advanced age adults:Is it possible to transplant safely?

ATİLLA E., BAŞ Ö., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017

Large Unsatained Cell (LUC) percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation

MERTER M., KÖKEN K., YÜKSEL M., DEMİR N., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017

Herpes SimplexVirus infection in patients after allogeneic hematopoetic stem cell transplantation

ATİLLA E., ÖZEL F., YILMAZ V., ATACA ATİLLA P., ATEŞAĞAOĞLU B., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017

Peripheral Blood Stem Cell Mobilization and collection from elderly patients 65 years with multipl myeloma: A , single center exprience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017

The outcome of Haploidentical Hematopoietic Celll Trnasplantations (Haplo HSCT)

ATİLLA E., ECE B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017

Acute GVHD and unreated/haploidentical Trnasplants incrreses the incidence of hemorrhagic cystitis in Allo- HSCT Recipients

TOPÇUOĞLU P., ATİLLA E., ATACA ATİLLA P., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017

Management and Outcome of Central Nerve System(CNS) Involvement in Acute Lymphoblastic Leukemia

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, orlando, Amerika Birleşik Devletleri, 22 - 26 Şubat 2017, cilt.23, ss.251

Management and Outcome of Central Nervous System (CNS) Involvement in Acute Lymphoblastic Leukemia (ALL)

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
BMT Tandem Meetings, 22 - 26 Şubat 2017

Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
BMT Tandem Meetings, 22 - 26 Şubat 2017

Allogeneic stem cell transplantation for chonic lymphocytic Leukemai

ATİLLA E., ATACA ATİLLA P., pekcan g., İLHAN O., GÜRMAN G., ÖZCAN M., et al.
BMT TANDEM MEETINGS, 22 - 26 Şubat 2017

Does Hypogammaglobulinemia at Diagosis Effects Survival and Infection Risk in Chronic Lymphocytic Leukemia CLL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.
ASH, 3 - 06 Aralık 2016

Comparison of Reduced Intensity Conditioning RIC Regimen and Myeloablative Conditioning MAC Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT for Adult Patients with Acute Leukemia

GÜRMAN G., AYDEMİR GÜLÖKSÜZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
ASH, 3 - 06 Aralık 2016

AKUT MYELOİD LÖSEMİDE FLOW SİTOMETRİ İLEİNDÜKSİYON SONRASI TESPİT EDİLEN CD34 HÜCRESAYISI SAĞKALIM VE RELAPSI ETKİLER

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

ALLOJENEİK KÖK HÜCRE NAKLİ OLAN AKUTLÖSEMİLERDE HAZIRLIK REJİMLERİNİNKARŞILAŞTIRILMASI

GÜLÖKSÜZ G. A., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

KRONİK LENFOSİTİK LÖSEMİ DE TANI ANINDAHİPOGAMAGLOBULİNEMİ SAĞKALIM VE ENFEKSİYONRİSKİ ÜZERİNDE ETKİLİ MİDİR

ATACA ATİLLA P., ATİLLA E., PEKCAN G., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

ALLOJENEİK KÖK HÜCRE NAKLİ YAPILANHASTALARDA PERİTRANSPLANT ALBUMİN DÜŞÜŞÜİLE GVHD İLİŞKİSİ

MERTER M., Şah F. T., ŞAHİN U., YALÇINER M., Kocabay H. E., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

TROMBOTİK MİKROANJİOPATİDE TERAPÖTİKPLAZMA DEĞİŞİMİ

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., TOPÇUOĞLU P., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji, Türkiye, 19 - 22 Ekim 2016

MYELODİSPLASTİK SENDROM HASTALARININOGATA SKORLAMASI İLE FLOW SİTOMETRİKOLARAK DEĞERLENDİRİLMESİ

ATİLLA E., ATACA ATİLLA P., TÜREDİ Ö., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
42.Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

GRAFT VERSUS HOST HASTALIĞINDAEKSTRAKORPOREAL FOTOFEREZİN YERİ

GÜNDÜZ M., ATİLLA E., ATACA ATİLLA P., AKAY B. N., ŞANLI H., TOPÇUOĞLU P., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

ALLOJENEİK KÖK HÜCRE NAKİL ÖNCESİ FAZLAKİLOLU OBEZ OLMANIN SAĞKALIM VE NÜKS İLEİLİŞKİSİ

ATİLLA E., ATACA ATİLLA P., CEYLAN A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42.ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 19 - 22 Ekim 2016

ALLOJENEİK KÖK HÜCRE NAKLİ HASTALARIMIZDAGELİŞEN KATATER TROMBOZLARI

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., TOPRAK S. K., YÜKSEL M., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

PRİMER MYELOFİBROZİS TE ALLOJENEİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ

CENGİZ G. S., GÜNDÜZ M., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., İLHAN O., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

AKUT LENFOSİTİK LÖSEMİDE ALL SANTRAL SİNİRSİSTEMİ SSS TUTULUMUNA YAKLAŞIM

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
42.Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

PERİFERİK T HÜCRELİ LENFOMALARDA OTOLOGHEMATOPOETİK KÖK HÜCRE TRANSPLANTASYONU TEK MERKEZ DENEYİMİ

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

Anti HLA Antikor Varlığının Allojeneik Kök Hücre Nakli Yapılan Hastalarda Engrafman Üzerine Etkisi: Tek Merkez Deneyimi

MERTER M., AYDOĞAN M., TEKEŞ M. A., ŞAHİN U., AYYILDIZ Ö. M., KOCABAY H. E., et al.
42. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 19 - 22 Ekim 2016, ss.60-61

BEING OVERWEIGHT PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IS RELATED TO BETTER SURVIVAL

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., AKAN H., et al.
78.th Annual Meeting of the Japanese Society of Hematology, 13 - 15 Ekim 2016

IS IT POSSIBLE TO DIAGNOSE LOW RISK MYELODYSPLASTIC SYNDROME MDS BY FLOW CYTOMETRY

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAN H., BEKSAÇ M., et al.
EHA, 9 - 12 Haziran 2016

OUR APPROACH TO HAIRY CELL LEUKEMIA HCL 31 YEARS OF EXPERIENCE

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
EHA, 9 - 12 Haziran 2016

CD34 POSITIVE CELL COUNT DETECTED BY MULTI COLOR FLOW CYTOMETRY MFC AFTER FIRST INDUCTION THERAPY IN ACUTE MYELOID LEUKEMIA AML EFFECTS ON SURVIVAL AND RELAPSE

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
EHA, 9 - 12 Haziran 2016

MANAGEMENT AND OUTCOME OF CENTRAL NERVOUS SYSTEM CNS INVOLVEMENT IN ACUTE LYMPHOBLASTIC LEUKEMIA ALL PRE AND POST TRANSPLANT Conference 21st Congress of the European Hematology AssociationLocation Copenhagen DENMARK

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
21st Congress of the European-Hematology-AssociationLocation: Copenhagen, DENMARK, 9 - 12 Haziran 2016, cilt.101

BEING OVERWEIGHT OBESE PRIOR TO ALLOJENEIK HEMATOPOIETIC STEM CELL TRANSPLANTATION ALLO HSCT IS RELATED TO BETTER OVERALL SURVIVAL OS AND DECREASED NON RELASE MORTALITY

ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., AKAN H., et al.
EHA, 9 - 12 Haziran 2016

EXTRACORPOREAL PHOTOPHERESIS SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., AKAY B. N., ŞANLI H., et al.
EHA, 9 - 12 Haziran 2016

THROMBOSIS IN PAROXYSMAL NOCTURNAL HEMOGLOBULINURIA PATIENTS SINGLE CENTER EXPERIENCE

MERTER M., ŞAHİN U., GÜNDÜZ M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., İLHAN O.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016

THERAPEUTIC THROMBOCYTAPHERESIS HIGHER PLATELET COUNTS SHOULD MATTER

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016

ARE AGE AND JAK2V617F MUTATION RELATED TO THROMBOSIS IN CHRONIC MYELOPROLIFERATIVE DISEASES

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., AKAN H., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016

THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY

ATİLLA E., ATACA ATİLLA P., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, 4 - 07 Mayıs 2016

Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
ASCO, 3 - 07 Haziran 2016

Effect of Cytomegalovirus Reactivation on Prognosis After Allogeneic Transplantation for Acute Leukemia with Active Disease Conditioned with a Sequential Regimen and Anti Thymocyte Globulin

GÜNDÜZ M., YÜKSEL M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 3 - 06 Nisan 2016

THE EFFICACY OF TYROSINE KINASE INHIBITORS WITH STEROID IN Ph ACUTE LYMPHOBLASTIC LEUKEMIA

GÜRMAN G., MERTER M., ATİLLA E., ŞAHİN U., TOPÇUOĞLU P., ARSLAN Ö., et al.
ASCO, 3 - 07 Haziran 2016

Succesfull treatment in primary central nervous system lymphoma

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., İLHAN O., et al.
ASCO, 3 - 07 Haziran 2016

AKTİF HASTALIKLI AKUT LÖSEMİDE ATG VEHAZIRLIK REJİMİ İLE ALLOJENİK NAKİL SONRASICMV REAKTİVASYONUNUN PROGNOZA ETKİSİ

GÜNDÜZ M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016

PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİHASTALARINDA ALLOJENEİK HEMATOPOETİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., TOPRAK S. K., TOPÇUOĞLU P., ŞAHİN U., GÜNDÜZ M., ATİLLA E., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016

Efficacy of High Dose Corticosteroid Premedication for the Prevention of Anti thymocyte Globulin Related Side Effects

MERTER M., ŞAHİN U., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation Location, 1 - 02 Mart 2016

Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

ŞAHİN U., YÜKSEL M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Kıbrıs (Kktc), 1 - 02 Mart 2016

Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia Subgroup Analysis of the Green Study

İLHAN O.
blood journal, 3 - 05 Aralık 2015

NILOTINIB RESULTS IN IMPROVED RATES OF MOLECULAR RESPONSE IN TURKISH NEWLY DIAGNOSED CML CP PATIENTS A 24 MONTH UPDATE

SAYDAM G., HAZNEDAROĞLU İ. C., İLHAN O., KAYNAR L., ALİ R., GÜVENÇ B., et al.
HAEMATOLOGICA, 11 - 14 Haziran 2015

MULTICENTER RETROSPECTIVE ANALYSIS OF TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

İLHAN O., SAYDAM G., HAZNEDAROĞLU İ. C., ÜNAL A., UĞUR BİLGİN A.
HAEMATOLOGICA, 11 - 14 Haziran 2015

Does chronic lymphocytic leukemia occur in younger adults in Turkey

ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., ÖZCAN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015

Allogeneic stem cell transplantation results in our myelodysplastic syndrome MDS patients

ATACA P., İLHAN O., ARSLAN Ö., TOPÇUOĞLU P., ATİLLA E., AKAN H.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015

Azacitidine in combination with ATRA valproic acid in elderly AML patients

ÖZCAN M., CİVRİZ BOZDAĞ S., İLHAN O., YÜKSEL M., ATACA P., ATİLLA E., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015

CML leukemic stem cell CML LSC Its existence in patients who achieved cytogenetic molecular response under treatment of TKI

İLHAN O., TOPRAK S. K., USLU A., ATİLLA E., ARSLAN Ö., ÖZCAN M., et al.
JOURNAL OF CLINICAL ONCOLOGY, 29 Mayıs - 02 Haziran 2015

Autologous Stem Cell Transplantation in Elderly Patients 60 years with Myeloma or Lymphoma Single Center Experience

gündüz m., ATACA P., ATİLLA E., gültekin p., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Single Centre Experienc

ŞAHİN U., MERTER M., ATİLLA E., TOPÇUOĞLU P., TOPRAK S. K., İLHAN O., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Different Doses of Anti Thymocyte Globulin ATG in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation

gültekin p., ateşağaoğlu b., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience

YÜKSEL M., gültekin p., bay m., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

upper and lower respiratory tract infections by respiratory viruses in adult recipients of allogeneic hematopoeitic stem cell transplantation Allo HSCT Single center

ŞAHİN D., ATİLLA E., USLU A., ATACA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma Single center experience

ATİLLA E., MERTER M., ATACA P., TOPRAK S. K., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Erythrocytosis following allogeneic hematopoietic stem cell transplantation in six cases

gültekin p., ATACA P., ATİLLA E., TOPRAK S. K., İLHAN O., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Effect of pretransplant body mass index on the clinical outcome after allogeneic stem cell transplantation in patients with hematologic malignancies a single center experience

GÖKMEN A., ender s., YÜKSEL M., İLHAN O., ARSLAN Ö., ÖZCAN M.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

HLA A allele mismatch 7 8 or 9 10 is the second best option after 8 8 or 10 10 matched unrelated donors An analysis on results from Turkish centers

BEKSAÇ M., TOPÇUOĞLU P., ARAT M., İLHAN O., GÜRMAN G., zafer g.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Characterization and MicroRNA Expression Profile Analysis of Mesenchymal Stem Cells Derived From Myelodysplastic Syndrome and Acute myeloid leukemia AML Patients and Comparison with Healthy Controls

özdoğan h., ATALAY A., İLHAN O.
BONE MARROW TRANSPLANTATION, 22 - 25 Mart 2015

Upper and Lower Respiratory Tract Infections by Respiratory Viruses by Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Single Center Experience

ŞAHİN D., ATİLLA E., CİVRİZ BOZDAĞ S., ATACA P., TOPRAK S. K., TOPÇUOĞLU P., et al.
41th EBMT Meeting, 22 - 25 Mart 2015

Generic Bioequivalent Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S440

TOPÇUOĞLU P., GÜLTAY D., ÖZTÜRK N., KILIÇ Ö., OKAY M., ERASLAN KARADAĞ Y., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015

Impact of Pre transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

UĞUR Ş., ERDAL H., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015
Kitap & Kitap Bölümleri

Editöryal

İLHAN O., TOPRAK S. K.
Hematoloji ve COVID-19 - 2020 (Kitap Editörlüğü), İlhan Osman, Toprak Selami Koçak, Editör, Türkiye Klinikleri, Ankara, ss.1-116, 2020
Metrikler

Yayın

427

Atıf (Scopus)

4092

H-İndeks (Scopus)

27

H-İndeks (Scholar)

37

Atıf (TrDizin)

18

H-İndeks (TrDizin)

2

Atıf (Diğer Toplam)

2

Açık Erişim

12